{
  "AIRRKnowledgeCommons": {
    "investigations": {
      "": {
        "akc_id": ""
      },
      "Investigation_PRJNA509910": {
        "akc_id": "91b95c18-c58b-465a-b7ef-01e8aaa4ae36",
        "name": "Yost et al., Clonal replacement of tumor-specific T cells following PD-1 blockade",
        "description": "Paired single-cell RNA and T cell receptor sequencing on 79,046 cells from site-matched tumors from patients with basal or squamous cell carcinoma before and after anti-PD-1 therapy.",
        "study_type": {
          "label": "Study",
          "id": "NCIT:C63536"
        },
        "archival_id": "PRJNA509910",
        "release_date": "2022-10-28T18:45:03.627212+00:00",
        "update_date": "2022-10-28T18:45:03.627212+00:00",
        "participants": [
          "1eaa8fe8-90d9-4349-92e3-26b06eed8d4f",
          "459a41c1-bab3-4833-9f29-8f4ee5e72b9c",
          "4d2f1000-55fd-4093-9aee-043dfc33c60f",
          "939d3fa8-a2e9-477b-9d53-bdcb5b07481c",
          "f1d0e517-305a-4fc1-ac88-a46629db6c9a",
          "1ab0789c-fa33-46a4-ae04-33453033fcf4",
          "d3fc0112-dca0-4336-86bf-cab9d8a7ac5a",
          "4ed08e63-dca2-4fb8-b81d-018eb849a1d5",
          "2848cf13-3bd5-46d7-84ae-766ca8d18329",
          "9bfec334-9c06-4fcf-90b8-ef4086c3573b",
          "dc9cb12c-47ef-4f97-8a68-85616361bd98",
          "69505dce-ee19-48c3-9c31-82fadfa36f0c",
          "34ef3424-65f7-47c3-af37-a5dcc98e819a",
          "ce344616-927a-4a86-8907-b5f7c1d4d7a7"
        ],
        "assays": [
          "e831eb9e-2da9-4762-b3bb-27bd15bcb07a",
          "b8e140f2-728d-4ba1-a5a2-6ca703579b8c",
          "5eb8c566-0365-4258-a648-c8d46ff22985",
          "e0a63684-5aae-4d0f-8fb7-bb039ce90c1b",
          "896decb0-3bd4-4a11-8b11-3574884e5c43",
          "c27f4826-16f5-4adf-9d95-b8f6900da3a0",
          "7bbef46a-4c2d-4c06-b76d-486c0e67dab4",
          "3b1029f7-8f50-4d41-9908-3145ae627c35",
          "914110f3-4163-4249-aaeb-4213a51f953a",
          "a58c8c85-8be6-43b3-9364-0638b629b2ff",
          "f45d516c-8439-4c55-b2de-5da0302a90dc",
          "926ed3d2-0e3b-4306-8cef-85cc3955e663",
          "4d82529a-d9e6-4f49-b168-df323d939413",
          "8142fe90-5262-4986-8878-c888dae77c50",
          "28e0735d-8850-411d-a9ad-ee334f119219",
          "c925321a-8c76-4068-b512-557d371835af",
          "e3bf4747-3244-4344-ac25-56ff03ada04b",
          "865c4e6a-1f1a-4dec-b1c5-1c9a82c2da33",
          "4eb2cb82-adb6-4b10-8a92-96e497674778",
          "9e7f394c-b499-491b-8cd2-d4b210462bdb",
          "389253bc-922b-49ca-93c8-4cd502b96eb7",
          "e7cf0fbd-a8c6-478f-8d4d-ba1efb1008f5",
          "52cd1311-abfa-4135-818d-ecd231d37ce4",
          "416be16f-9416-4654-aa8b-523ede3b8f97",
          "2f32527b-ce4d-4578-8c8f-af8fd00d055f",
          "a3d05024-9195-4cff-ad88-f995cbe419a1",
          "e84bb766-899f-4540-b8a8-8bf33a8d5b04",
          "f57b3c47-dfb8-451b-b5bb-950e6c81b4ed",
          "282ffe6a-efd9-45e6-9bde-40487d7fcf6a",
          "2bf16079-393d-41d6-b467-d55cb9ad7211",
          "17f88c83-f2cf-4450-aa48-0b9668b608a0",
          "eb448c60-9ea2-4a13-b829-9d13783a2b1f",
          "4fcbe1d3-f3a2-4dbd-83b8-3c2180e73dd8",
          "d1dae7b7-171e-49b8-93a8-48cffdf32aa9",
          "70c78919-58de-493d-ad0e-802484f76ac4",
          "04d07719-20f5-4329-81f3-96fa0b0b71c1",
          "ea6eb625-cd76-4967-bd6f-a3204087c80f",
          "bb9a6377-c63f-4abd-9e09-ca4a8a3111a7",
          "f71b2226-835d-481b-a6bd-84883a5f17b4",
          "6075adfb-1bef-4ca1-b742-d83cc5ec4a6d",
          "d4e39d53-14aa-498b-aecd-19058cf711a0",
          "39ed8c55-b185-4deb-a4fb-ceae743e3a6e",
          "fc71d81b-1e32-4973-9b46-99eff10380d0",
          "e951e225-bc86-4aa1-b6dd-c2b71f046870",
          "1f7f090b-b3ab-4d87-9612-79ad0db07eab",
          "40b87d10-4b32-4e03-ae63-15f35a1dc4a3",
          "851a594c-00c5-4bc8-be5e-1d85d7c8ace2",
          "b17abd12-ef79-41f5-8182-1f9c87b42f77",
          "110b774e-491e-4847-b36e-8f6ecd7e0fe7",
          "9ccc414f-e3c1-4678-a05b-7e6c963c183f",
          "1a2c9593-e7a0-4dbf-a4bb-c8e13c98b547",
          "7472ad7d-42b2-4abd-beae-3869da54987a",
          "29ea3f41-f12f-4d6d-aab3-82637f036a5e",
          "82489118-76a5-4b41-a619-5a4c206bb237",
          "920e930d-e046-4a44-8666-865a72926b04",
          "6f0f1400-2718-4915-a7c3-3fa789824f99",
          "e7d04f77-6b06-46d2-b40b-53e4548003c4",
          "36832af5-eae1-4466-b1ee-9126513c1015",
          "30f62542-f9ab-401c-85d9-4111189689ae",
          "da4214e9-ae1e-4ca7-aa8a-415c1ada45d1",
          "9d77c17a-332a-47c1-8807-23b6a4f70e7d",
          "d658f6b7-cd8b-45e3-b5ba-3b21baf4bcc5",
          "bedabad9-c9ef-4a0d-8edf-6a8fc1e6af90",
          "27cc8fb2-c9b6-4346-b1db-44bae65e2809",
          "67188c81-3672-4bfb-9ea2-664a739bfe95",
          "ce72eac1-d49a-47bc-a93e-e5dc0d584116",
          "a4c2d121-4fc3-4125-9b5f-389cf359b935",
          "d4594b89-1a59-4e3a-bd77-a351768cfbb8",
          "ece68b4c-742b-4193-8c6d-9aea4ddace6a",
          "550aa739-1c66-43e2-9618-7d8b0c21d3e3",
          "2b740a52-50c0-4b9e-a51e-e81533641bcc",
          "d4530fa5-f498-4d60-911d-4889e3ac9896",
          "0c79444a-8e9b-4e0e-bbf1-65ec4291fcb0",
          "911f9112-711a-4153-be8b-dfa7fc932c0c",
          "4b96c15b-31d5-4408-8c47-784ad19a5c29",
          "c44fb362-5873-47b7-8085-3f33dbd50b66",
          "d01d14dd-9bf9-4b3c-b0a0-54fc508183b3",
          "e7c86b7b-8641-4ac4-bc01-2d3d915d7da8",
          "bfdd1cfd-4edb-4174-b81d-d084657eb615",
          "2bf8bbfb-ece2-485e-bd51-96faac4a8ca0",
          "6f7e1ea1-93e9-44e7-baa3-d79870994a04",
          "c4bcafa3-d2bc-4830-9d2a-18666e8b06f2",
          "6acff83d-c606-492a-8f8c-d20f95e4e1da",
          "f1ff5a60-66de-46d4-bb5c-bab27b271f8f",
          "7a07c80f-3b03-47cb-999d-cb7b2839a399",
          "7682410e-0816-49a7-a41b-b0ce286c83ef",
          "14d34830-3a4b-4231-9e55-55ec783901cd",
          "af684493-a24f-446d-a524-d82ad93ab40b",
          "3c5d1593-3ebc-4b76-a464-e663be89c4a4",
          "fbf8c4fd-4439-4b9c-ba09-c3d2f1354457",
          "e9a27f3a-ee69-4f7a-bc2e-fe89b8a06eec",
          "e3f2ae98-2d89-4f6d-841a-868c22ab6e2a",
          "9c7dcd12-05da-4edd-b6c0-0a4306a066ae",
          "d27d434e-04dd-4ee4-b9d5-be3c393e77e1",
          "39013701-49a1-43d2-ab55-2ab7c9258d70",
          "4b996025-c87f-4bde-a77b-55901be1e5c1",
          "76060d9c-d571-481e-ab5a-2736b868d703",
          "fe944cd3-b005-4d98-b7c3-3c68584fdbcb",
          "576a15f5-03b9-43b3-8b68-29da4d420392",
          "8313b5e2-5fc4-4226-b4e0-30f374ddfc99",
          "6c594565-57a1-475a-939c-a5e74234552a",
          "3d3bfd7f-d955-43db-83de-701cd0c967d2",
          "18cf9c8e-b7a6-4a4a-a9da-d55b2aa0823b",
          "c6076b49-f3dc-4aa6-b1b4-6487c3b69604",
          "a07da864-7a7c-4f32-bc83-95b8483f827b",
          "1bf2128e-bcd9-4a29-82b4-a1b27305edfa",
          "86b4c3fd-bdba-492a-b5fb-c7aae266261d",
          "d62bdecf-714c-47ed-b649-af292bc8080c",
          "3ddc24eb-8108-4550-bad5-a5874c7fa48e",
          "eb0085bc-f4e2-4c44-b3e6-ac63a4e37f24",
          "06fd3f7c-5a40-4f4c-876f-bc64b2f5d291",
          "67134679-3773-4433-a3b4-4f780ee15051",
          "66163126-c19f-441d-adee-7b26e9a13376",
          "1e1bb369-f773-4065-a60e-11d33b0415c9",
          "70169a86-7977-4468-98e8-c1c0914cdac9",
          "5ff6e9e5-8e32-4bbe-87f9-459ae817b519",
          "56176711-a2ac-4e3a-bf3b-0137a662c0d8",
          "df88c448-7d29-4132-a073-ba7a51ae8d32",
          "467d75f3-1744-4acc-b873-ad7752dc7058",
          "5f7ececd-380b-4fb9-9da9-cfb88424c367",
          "9d82c75f-20ed-4a5c-93f9-5e0296fe9d0e",
          "935b8392-cc56-4d8b-a962-42cf6afd73e9",
          "4363c550-9b29-40e2-b1a5-0ae6e071614c",
          "733fca84-f710-41b7-b1c1-c36df68f9f6d",
          "340b31bf-3541-454c-bfd3-9a6d2bc208d0",
          "9dc3af4e-0bdf-4931-89fc-566129b9b4d7",
          "a35fe798-17c9-4d3b-98fc-6e51bc66a7c7",
          "5e5207f9-87da-4ee3-9e9b-82d16114f288",
          "6dc25a47-5c9f-4103-9651-17d52475e6a3",
          "054f733d-223c-415c-8779-2811c77dc579",
          "10c7c3a9-2b92-4c3a-8b63-99688696b278",
          "1afb7dad-f52e-4d34-a44e-61480cd45ddf",
          "fe3351c6-1cf0-4633-9777-a5ab4007926e",
          "d2d19b14-f254-4531-805c-aac10739f098",
          "973d093d-89c1-4699-8e09-70af4f780885",
          "954e156f-a070-4d78-8a37-65efd91075f3"
        ],
        "documents": [
          "81642f62-5a6a-4d4e-b035-7372ae93b025"
        ]
      }
    },
    "references": {
      "Reference_PRJNA509910": {
        "source_uri": "",
        "sources": "DOI:10.1038/s41591-019-0522-3",
        "investigations": [
          "",
          "91b95c18-c58b-465a-b7ef-01e8aaa4ae36"
        ],
        "akc_id": "81642f62-5a6a-4d4e-b035-7372ae93b025"
      }
    },
    "study_arms": {
      "StudyArm_post treatment": {
        "akc_id": "d229ef91-46c4-45de-885d-6325b08197da",
        "name": "post treatment",
        "investigation": "91b95c18-c58b-465a-b7ef-01e8aaa4ae36",
        "inclusion_criteria": "include: advanced or metastatic BCC or SCC not suitable for surgical resection; exclude: previous exposure to checkpoint blockade agents and systemic immunosuppressant use, treatment with radiotherapy or other anti-cancer agents within 4 weeks of first biopsy"
      },
      "StudyArm_pre treatment": {
        "akc_id": "bddbdbc4-b207-453a-ab4d-84ed5e1a5ef5",
        "name": "pre treatment",
        "investigation": "91b95c18-c58b-465a-b7ef-01e8aaa4ae36",
        "inclusion_criteria": "include: advanced or metastatic BCC or SCC not suitable for surgical resection; exclude: previous exposure to checkpoint blockade agents and systemic immunosuppressant use, treatment with radiotherapy or other anti-cancer agents within 4 weeks of first biopsy"
      }
    },
    "participants": {
      "Participant_su001": {
        "akc_id": "1eaa8fe8-90d9-4349-92e3-26b06eed8d4f",
        "name": "su001",
        "study_arm": "d229ef91-46c4-45de-885d-6325b08197da",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection"
      },
      "Participant_su002": {
        "akc_id": "459a41c1-bab3-4833-9f29-8f4ee5e72b9c",
        "name": "su002",
        "study_arm": "d229ef91-46c4-45de-885d-6325b08197da",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection"
      },
      "Participant_su003": {
        "akc_id": "4d2f1000-55fd-4093-9aee-043dfc33c60f",
        "name": "su003",
        "study_arm": "d229ef91-46c4-45de-885d-6325b08197da",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection"
      },
      "Participant_su004": {
        "akc_id": "939d3fa8-a2e9-477b-9d53-bdcb5b07481c",
        "name": "su004",
        "study_arm": "d229ef91-46c4-45de-885d-6325b08197da",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection"
      },
      "Participant_su005": {
        "akc_id": "f1d0e517-305a-4fc1-ac88-a46629db6c9a",
        "name": "su005",
        "study_arm": "d229ef91-46c4-45de-885d-6325b08197da",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection"
      },
      "Participant_su006": {
        "akc_id": "1ab0789c-fa33-46a4-ae04-33453033fcf4",
        "name": "su006",
        "study_arm": "d229ef91-46c4-45de-885d-6325b08197da",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection"
      },
      "Participant_su007": {
        "akc_id": "d3fc0112-dca0-4336-86bf-cab9d8a7ac5a",
        "name": "su007",
        "study_arm": "d229ef91-46c4-45de-885d-6325b08197da",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection"
      },
      "Participant_su008": {
        "akc_id": "4ed08e63-dca2-4fb8-b81d-018eb849a1d5",
        "name": "su008",
        "study_arm": "d229ef91-46c4-45de-885d-6325b08197da",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection"
      },
      "Participant_su009": {
        "akc_id": "2848cf13-3bd5-46d7-84ae-766ca8d18329",
        "name": "su009",
        "study_arm": "d229ef91-46c4-45de-885d-6325b08197da",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection"
      },
      "Participant_su010": {
        "akc_id": "9bfec334-9c06-4fcf-90b8-ef4086c3573b",
        "name": "su010",
        "study_arm": "d229ef91-46c4-45de-885d-6325b08197da",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection"
      },
      "Participant_su011": {
        "akc_id": "dc9cb12c-47ef-4f97-8a68-85616361bd98",
        "name": "su011",
        "study_arm": "d229ef91-46c4-45de-885d-6325b08197da",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection"
      },
      "Participant_su012": {
        "akc_id": "69505dce-ee19-48c3-9c31-82fadfa36f0c",
        "name": "su012",
        "study_arm": "d229ef91-46c4-45de-885d-6325b08197da",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection"
      },
      "Participant_su013": {
        "akc_id": "34ef3424-65f7-47c3-af37-a5dcc98e819a",
        "name": "su013",
        "study_arm": "d229ef91-46c4-45de-885d-6325b08197da",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection"
      },
      "Participant_su014": {
        "akc_id": "ce344616-927a-4a86-8907-b5f7c1d4d7a7",
        "name": "su014",
        "study_arm": "d229ef91-46c4-45de-885d-6325b08197da",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection"
      }
    },
    "life_events": {
      "LifeEvent_Participant_su001_su001_post": {
        "akc_id": "7b8076cc-a7a8-4dbb-b34c-894e6427fc53",
        "participant": "1eaa8fe8-90d9-4349-92e3-26b06eed8d4f"
      },
      "LifeEvent_ImmuneExposure_su001_su001_post": {
        "akc_id": "596b1c99-2069-4ff2-9c36-7ce9414c4674",
        "participant": "1eaa8fe8-90d9-4349-92e3-26b06eed8d4f"
      },
      "LifeEvent_Specimen_su001_su001_post": {
        "akc_id": "fa218a6f-ecc5-4c91-bb9a-89475006d5af",
        "participant": "1eaa8fe8-90d9-4349-92e3-26b06eed8d4f",
        "t0_event": "post treatment",
        "start": 83,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su001_su001_pre1": {
        "akc_id": "2a97009a-caaa-4df0-9809-84d36315b525",
        "adc_link_tag": "LifeEvent_Participant_su001_su001_pre1",
        "adc_repertoire_id": "PRJNA509910-su001_pre1-TRA",
        "adc_sample_processing_id": "PRJNA509910-su001_pre1-TRA",
        "adc_data_processing_id": "PRJNA509910-su001_pre1",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su001",
        "adc_sample_id": "su001_pre1",
        "adc_study_group_description": "pre treatment",
        "participant": "1eaa8fe8-90d9-4349-92e3-26b06eed8d4f"
      },
      "LifeEvent_Specimen_su001_su001_pre1": {
        "akc_id": "83ad8e44-f846-46fa-ae39-e5d9bf31a87a",
        "participant": "1eaa8fe8-90d9-4349-92e3-26b06eed8d4f",
        "t0_event": "pre treatment",
        "start": 239,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su001_su001_pre2": {
        "akc_id": "fb0c239e-da4f-4678-a149-ca6b263137aa",
        "adc_link_tag": "LifeEvent_Participant_su001_su001_pre2",
        "adc_repertoire_id": "PRJNA509910-su001_pre2-TRA",
        "adc_sample_processing_id": "PRJNA509910-su001_pre2-TRA",
        "adc_data_processing_id": "PRJNA509910-su001_pre2",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su001",
        "adc_sample_id": "su001_pre2",
        "adc_study_group_description": "pre treatment",
        "participant": "1eaa8fe8-90d9-4349-92e3-26b06eed8d4f"
      },
      "LifeEvent_Specimen_su001_su001_pre2": {
        "akc_id": "55fbe8e4-2791-445b-8275-e26ca632b035",
        "participant": "1eaa8fe8-90d9-4349-92e3-26b06eed8d4f",
        "t0_event": "pre treatment",
        "start": 78,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su002_su002_post": {
        "akc_id": "1d92e0e7-b431-44ac-b9f2-c710ce1d7321",
        "participant": "459a41c1-bab3-4833-9f29-8f4ee5e72b9c"
      },
      "LifeEvent_ImmuneExposure_su002_su002_post": {
        "akc_id": "8c4abb7f-72af-4a10-be76-3bcc73b8b299",
        "participant": "459a41c1-bab3-4833-9f29-8f4ee5e72b9c"
      },
      "LifeEvent_Specimen_su002_su002_post": {
        "akc_id": "2847db36-49bc-4ff8-a797-0ccd82b1d36d",
        "participant": "459a41c1-bab3-4833-9f29-8f4ee5e72b9c",
        "t0_event": "post treatment",
        "start": 62,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su002_su002_pre": {
        "akc_id": "c7a8760d-9659-4410-b16e-465a8f691f25",
        "adc_link_tag": "LifeEvent_Participant_su002_su002_pre",
        "adc_repertoire_id": "PRJNA509910-su002_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su002_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su002_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su002",
        "adc_sample_id": "su002_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "459a41c1-bab3-4833-9f29-8f4ee5e72b9c"
      },
      "LifeEvent_Specimen_su002_su002_pre": {
        "akc_id": "c8a232db-32a8-412f-a5e4-5d6df3c37b3f",
        "participant": "459a41c1-bab3-4833-9f29-8f4ee5e72b9c",
        "t0_event": "pre treatment",
        "start": 0,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su003_su003_post": {
        "akc_id": "c21b50a2-6c7d-4b78-a3ff-1039b1472649",
        "participant": "4d2f1000-55fd-4093-9aee-043dfc33c60f"
      },
      "LifeEvent_ImmuneExposure_su003_su003_post": {
        "akc_id": "68a9c9f2-493b-4580-88dd-c525b14c85e5",
        "participant": "4d2f1000-55fd-4093-9aee-043dfc33c60f"
      },
      "LifeEvent_Specimen_su003_su003_post": {
        "akc_id": "073c5003-280b-44c0-b918-852b28ab84e4",
        "participant": "4d2f1000-55fd-4093-9aee-043dfc33c60f",
        "t0_event": "post treatment",
        "start": 16,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su003_su003_pre": {
        "akc_id": "ad47bab9-8e83-4986-9ca7-5829ed82752f",
        "adc_link_tag": "LifeEvent_Participant_su003_su003_pre",
        "adc_repertoire_id": "PRJNA509910-su003_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su003_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su003_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su003",
        "adc_sample_id": "su003_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "4d2f1000-55fd-4093-9aee-043dfc33c60f"
      },
      "LifeEvent_Specimen_su003_su003_pre": {
        "akc_id": "39ed73a5-1251-4672-bb22-86d0c1843d3c",
        "participant": "4d2f1000-55fd-4093-9aee-043dfc33c60f",
        "t0_event": "pre treatment",
        "start": 243,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su004_su004_post": {
        "akc_id": "b3ab18ff-ccc9-4a39-b3e5-eea9965ea70c",
        "participant": "939d3fa8-a2e9-477b-9d53-bdcb5b07481c"
      },
      "LifeEvent_ImmuneExposure_su004_su004_post": {
        "akc_id": "2a4742ad-2440-4f7d-97a0-7ea149ea9fe7",
        "participant": "939d3fa8-a2e9-477b-9d53-bdcb5b07481c"
      },
      "LifeEvent_Specimen_su004_su004_post": {
        "akc_id": "5f72cf78-1000-4db7-afd1-f7d3409e1d06",
        "participant": "939d3fa8-a2e9-477b-9d53-bdcb5b07481c",
        "t0_event": "post treatment",
        "start": 38,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su004_su004_pre": {
        "akc_id": "33d06d0d-a390-40fb-9dd3-4c60359736b3",
        "adc_link_tag": "LifeEvent_Participant_su004_su004_pre",
        "adc_repertoire_id": "PRJNA509910-su004_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su004_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su004_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su004",
        "adc_sample_id": "su004_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "939d3fa8-a2e9-477b-9d53-bdcb5b07481c"
      },
      "LifeEvent_Specimen_su004_su004_pre": {
        "akc_id": "e000e37d-2729-4549-95ad-58e8c2c16d91",
        "participant": "939d3fa8-a2e9-477b-9d53-bdcb5b07481c",
        "t0_event": "pre treatment",
        "start": 1,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su005_su005_post": {
        "akc_id": "8f9217cf-6933-48d0-9719-3ad32504dd56",
        "participant": "f1d0e517-305a-4fc1-ac88-a46629db6c9a"
      },
      "LifeEvent_ImmuneExposure_su005_su005_post": {
        "akc_id": "b2a58dad-f807-4841-ae06-6f2024ab06b3",
        "participant": "f1d0e517-305a-4fc1-ac88-a46629db6c9a"
      },
      "LifeEvent_Specimen_su005_su005_post": {
        "akc_id": "89f2ebcd-d221-408e-877c-fb9f1728bb31",
        "participant": "f1d0e517-305a-4fc1-ac88-a46629db6c9a",
        "t0_event": "post treatment",
        "start": 105,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su005_su005_pre": {
        "akc_id": "d9c61eb0-403e-4f3f-8ac5-fd3abc33ce38",
        "adc_link_tag": "LifeEvent_Participant_su005_su005_pre",
        "adc_repertoire_id": "PRJNA509910-su005_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su005_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su005_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su005",
        "adc_sample_id": "su005_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "f1d0e517-305a-4fc1-ac88-a46629db6c9a"
      },
      "LifeEvent_Specimen_su005_su005_pre": {
        "akc_id": "f0d0a291-6ff3-4f64-9347-64c96183c19d",
        "participant": "f1d0e517-305a-4fc1-ac88-a46629db6c9a",
        "t0_event": "pre treatment",
        "start": 0,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su006_su006_post": {
        "akc_id": "9933de41-1fee-4fed-befe-1c013416bd2b",
        "participant": "1ab0789c-fa33-46a4-ae04-33453033fcf4"
      },
      "LifeEvent_ImmuneExposure_su006_su006_post": {
        "akc_id": "1a121e91-caee-431f-a845-2f5bad5e8f83",
        "participant": "1ab0789c-fa33-46a4-ae04-33453033fcf4"
      },
      "LifeEvent_Specimen_su006_su006_post": {
        "akc_id": "2680a47a-c4a0-46b7-bf71-c6cdc6e147ae",
        "participant": "1ab0789c-fa33-46a4-ae04-33453033fcf4",
        "t0_event": "post treatment",
        "start": 21,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su006_su006_pre": {
        "akc_id": "c976524c-8878-4159-b944-b131e425ab87",
        "adc_link_tag": "LifeEvent_Participant_su006_su006_pre",
        "adc_repertoire_id": "PRJNA509910-su006_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su006_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su006_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su006",
        "adc_sample_id": "su006_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "1ab0789c-fa33-46a4-ae04-33453033fcf4"
      },
      "LifeEvent_Specimen_su006_su006_pre": {
        "akc_id": "cfd11d04-4c01-4e18-a0a8-47007c2d36cd",
        "participant": "1ab0789c-fa33-46a4-ae04-33453033fcf4",
        "t0_event": "pre treatment",
        "start": 0,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su007_su007_post": {
        "akc_id": "aadb7e31-6be3-4d20-a81d-54b9840509dd",
        "participant": "d3fc0112-dca0-4336-86bf-cab9d8a7ac5a"
      },
      "LifeEvent_ImmuneExposure_su007_su007_post": {
        "akc_id": "a7d881f0-d3a4-4f3c-8db1-93b5f185b23d",
        "participant": "d3fc0112-dca0-4336-86bf-cab9d8a7ac5a"
      },
      "LifeEvent_Specimen_su007_su007_post": {
        "akc_id": "f623ca5d-36c3-4f03-8586-1adc60d2e010",
        "participant": "d3fc0112-dca0-4336-86bf-cab9d8a7ac5a",
        "t0_event": "post treatment",
        "start": 60,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su007_su007_pre": {
        "akc_id": "ee924af9-4b3e-48b7-8311-4f6fa245e330",
        "adc_link_tag": "LifeEvent_Participant_su007_su007_pre",
        "adc_repertoire_id": "PRJNA509910-su007_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su007_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su007_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su007",
        "adc_sample_id": "su007_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "d3fc0112-dca0-4336-86bf-cab9d8a7ac5a"
      },
      "LifeEvent_Specimen_su007_su007_pre": {
        "akc_id": "98abbd60-a148-40c3-b1cb-68fe49b1ef8d",
        "participant": "d3fc0112-dca0-4336-86bf-cab9d8a7ac5a",
        "t0_event": "pre treatment",
        "start": 3,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su008_su008_post": {
        "akc_id": "5cc88896-c9e5-4856-bfcc-c10150d881ea",
        "participant": "4ed08e63-dca2-4fb8-b81d-018eb849a1d5"
      },
      "LifeEvent_ImmuneExposure_su008_su008_post": {
        "akc_id": "8a28f877-96f0-4f13-9d0b-96c6b438b049",
        "participant": "4ed08e63-dca2-4fb8-b81d-018eb849a1d5"
      },
      "LifeEvent_Specimen_su008_su008_post": {
        "akc_id": "18b82bec-78f2-422d-9683-855b0f977fbb",
        "participant": "4ed08e63-dca2-4fb8-b81d-018eb849a1d5",
        "t0_event": "post treatment",
        "start": 43,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su008_su008_pre": {
        "akc_id": "97a30cd6-af15-4418-b50a-a91327a2fe53",
        "adc_link_tag": "LifeEvent_Participant_su008_su008_pre",
        "adc_repertoire_id": "PRJNA509910-su008_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su008_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su008_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su008",
        "adc_sample_id": "su008_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "4ed08e63-dca2-4fb8-b81d-018eb849a1d5"
      },
      "LifeEvent_Specimen_su008_su008_pre": {
        "akc_id": "b9c6874b-f185-434e-a7ba-3612da1612af",
        "participant": "4ed08e63-dca2-4fb8-b81d-018eb849a1d5",
        "t0_event": "pre treatment",
        "start": 91,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su009_su009_post": {
        "akc_id": "452b9a65-b655-487d-920e-29f8f2be8e97",
        "participant": "2848cf13-3bd5-46d7-84ae-766ca8d18329"
      },
      "LifeEvent_ImmuneExposure_su009_su009_post": {
        "akc_id": "d94ad7a4-84b7-4a44-87f9-c5bac367f8f2",
        "participant": "2848cf13-3bd5-46d7-84ae-766ca8d18329"
      },
      "LifeEvent_Specimen_su009_su009_post": {
        "akc_id": "31478d05-52e0-49f1-b76d-ad996d4db8e7",
        "participant": "2848cf13-3bd5-46d7-84ae-766ca8d18329",
        "t0_event": "post treatment",
        "start": 21,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su009_su009_pre": {
        "akc_id": "c784c96c-3297-43c3-9054-e8d0be85c247",
        "adc_link_tag": "LifeEvent_Participant_su009_su009_pre",
        "adc_repertoire_id": "PRJNA509910-su009_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su009_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su009_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su009",
        "adc_sample_id": "su009_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "2848cf13-3bd5-46d7-84ae-766ca8d18329"
      },
      "LifeEvent_Specimen_su009_su009_pre": {
        "akc_id": "2276e9c4-7e98-4ca6-a513-786d9a67f202",
        "participant": "2848cf13-3bd5-46d7-84ae-766ca8d18329",
        "t0_event": "pre treatment",
        "start": 0,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su010_su010_post_BCC": {
        "akc_id": "e6845bd9-238b-412c-b6f7-d4a5e4497bb0",
        "participant": "9bfec334-9c06-4fcf-90b8-ef4086c3573b"
      },
      "LifeEvent_ImmuneExposure_su010_su010_post_BCC": {
        "akc_id": "51f0eb13-b855-4705-83a6-43c338a8bcf1",
        "participant": "9bfec334-9c06-4fcf-90b8-ef4086c3573b"
      },
      "LifeEvent_Specimen_su010_su010_post_BCC": {
        "akc_id": "36ea152e-2e31-4cb0-bcfa-9f489d260496",
        "participant": "9bfec334-9c06-4fcf-90b8-ef4086c3573b",
        "t0_event": "post treatment",
        "start": 21,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su010_su010_post_SCC": {
        "akc_id": "c905912e-b5bb-417d-9825-d9539a45ce29",
        "adc_link_tag": "LifeEvent_Participant_su010_su010_post_SCC",
        "adc_repertoire_id": "PRJNA509910-su010_post_SCC-TRA",
        "adc_sample_processing_id": "PRJNA509910-su010_post_SCC-TRA",
        "adc_data_processing_id": "PRJNA509910-su010_post_SCC",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su010",
        "adc_sample_id": "su010_post_SCC",
        "adc_study_group_description": "post treatment",
        "participant": "9bfec334-9c06-4fcf-90b8-ef4086c3573b"
      },
      "LifeEvent_ImmuneExposure_su010_su010_post_SCC": {
        "akc_id": "0d05213e-be31-4315-8a22-3fa6bfe68306",
        "participant": "9bfec334-9c06-4fcf-90b8-ef4086c3573b"
      },
      "LifeEvent_Specimen_su010_su010_post_SCC": {
        "akc_id": "2b19bacc-7a2d-450e-ada9-d023aaf75f74",
        "participant": "9bfec334-9c06-4fcf-90b8-ef4086c3573b",
        "t0_event": "post treatment",
        "start": 21,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su010_su010_post_SCC_CD39": {
        "akc_id": "d3dd2a1e-d5eb-42b4-8d09-443d50bd8551",
        "adc_link_tag": "LifeEvent_Participant_su010_su010_post_SCC_CD39",
        "adc_repertoire_id": "PRJNA509910-su010_post_SCC_CD39-TRA",
        "adc_sample_processing_id": "PRJNA509910-su010_post_SCC_CD39-TRA",
        "adc_data_processing_id": "PRJNA509910-su010_post_SCC_CD39",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su010",
        "adc_sample_id": "su010_post_SCC_CD39",
        "adc_study_group_description": "post treatment",
        "participant": "9bfec334-9c06-4fcf-90b8-ef4086c3573b"
      },
      "LifeEvent_Specimen_su010_su010_post_SCC_CD39": {
        "akc_id": "eccc1d81-cdb0-4ed5-9776-6c201c23015e",
        "participant": "9bfec334-9c06-4fcf-90b8-ef4086c3573b",
        "t0_event": "post treatment",
        "start": 21,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su010_su010_pre_BCC": {
        "akc_id": "bd55722a-9a0d-4ccc-9c64-bb43acac470b",
        "adc_link_tag": "LifeEvent_Participant_su010_su010_pre_BCC",
        "adc_repertoire_id": "PRJNA509910-su010_pre_BCC-TRA",
        "adc_sample_processing_id": "PRJNA509910-su010_pre_BCC-TRA",
        "adc_data_processing_id": "PRJNA509910-su010_pre_BCC",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su010",
        "adc_sample_id": "su010_pre_BCC",
        "adc_study_group_description": "pre treatment",
        "participant": "9bfec334-9c06-4fcf-90b8-ef4086c3573b"
      },
      "LifeEvent_Specimen_su010_su010_pre_BCC": {
        "akc_id": "bddd3089-6bd5-4a4a-81e9-35a336e6484b",
        "participant": "9bfec334-9c06-4fcf-90b8-ef4086c3573b",
        "t0_event": "pre treatment",
        "start": 6,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su010_su010_pre_SCC_rep1": {
        "akc_id": "a1ea8b78-0fbf-46d6-93b3-98d5cfd3ed0c",
        "adc_link_tag": "LifeEvent_Participant_su010_su010_pre_SCC_rep1",
        "adc_repertoire_id": "PRJNA509910-su010_pre_SCC_rep1-TRA",
        "adc_sample_processing_id": "PRJNA509910-su010_pre_SCC_rep1-TRA",
        "adc_data_processing_id": "PRJNA509910-su010_pre_SCC_rep1",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su010",
        "adc_sample_id": "su010_pre_SCC_rep1",
        "adc_study_group_description": "pre treatment",
        "participant": "9bfec334-9c06-4fcf-90b8-ef4086c3573b"
      },
      "LifeEvent_Specimen_su010_su010_pre_SCC_rep1": {
        "akc_id": "9625fcfb-fbb8-4f8d-b899-a1e92e864a05",
        "participant": "9bfec334-9c06-4fcf-90b8-ef4086c3573b",
        "t0_event": "pre treatment",
        "start": 6,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su010_su010_pre_SCC_rep2": {
        "akc_id": "88d5b3be-4466-4994-a560-44b3b7c5f5ee",
        "adc_link_tag": "LifeEvent_Participant_su010_su010_pre_SCC_rep2",
        "adc_repertoire_id": "PRJNA509910-su010_pre_SCC_rep2-TRA",
        "adc_sample_processing_id": "PRJNA509910-su010_pre_SCC_rep2-TRA",
        "adc_data_processing_id": "PRJNA509910-su010_pre_SCC_rep2",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su010",
        "adc_sample_id": "su010_pre_SCC_rep2",
        "adc_study_group_description": "pre treatment",
        "participant": "9bfec334-9c06-4fcf-90b8-ef4086c3573b"
      },
      "LifeEvent_Specimen_su010_su010_pre_SCC_rep2": {
        "akc_id": "f8272266-8ea8-45bd-82f3-0be8548fffc7",
        "participant": "9bfec334-9c06-4fcf-90b8-ef4086c3573b",
        "t0_event": "pre treatment",
        "start": 6,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su011_su011_post": {
        "akc_id": "f53c740e-a57b-445a-b21f-abfc08aa3271",
        "participant": "dc9cb12c-47ef-4f97-8a68-85616361bd98"
      },
      "LifeEvent_ImmuneExposure_su011_su011_post": {
        "akc_id": "90868a68-72eb-4868-a49c-b179c20ff1c9",
        "participant": "dc9cb12c-47ef-4f97-8a68-85616361bd98"
      },
      "LifeEvent_Specimen_su011_su011_post": {
        "akc_id": "135e7043-7822-4401-b11f-08b924ba4d9c",
        "participant": "dc9cb12c-47ef-4f97-8a68-85616361bd98",
        "t0_event": "post treatment",
        "start": 29,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su011_su011_pre_rep1": {
        "akc_id": "df7bc577-402c-423e-aca5-abaa6fb873ef",
        "adc_link_tag": "LifeEvent_Participant_su011_su011_pre_rep1",
        "adc_repertoire_id": "PRJNA509910-su011_pre_rep1-TRA",
        "adc_sample_processing_id": "PRJNA509910-su011_pre_rep1-TRA",
        "adc_data_processing_id": "PRJNA509910-su011_pre_rep1",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su011",
        "adc_sample_id": "su011_pre_rep1",
        "adc_study_group_description": "pre treatment",
        "participant": "dc9cb12c-47ef-4f97-8a68-85616361bd98"
      },
      "LifeEvent_Specimen_su011_su011_pre_rep1": {
        "akc_id": "d26617a1-818f-4f15-acee-db3ce98ef522",
        "participant": "dc9cb12c-47ef-4f97-8a68-85616361bd98",
        "t0_event": "pre treatment",
        "start": 13,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su011_su011_pre_rep2": {
        "akc_id": "166f15dd-a2bf-4274-9a0f-d04a6f6da5fb",
        "adc_link_tag": "LifeEvent_Participant_su011_su011_pre_rep2",
        "adc_repertoire_id": "PRJNA509910-su011_pre_rep2-TRA",
        "adc_sample_processing_id": "PRJNA509910-su011_pre_rep2-TRA",
        "adc_data_processing_id": "PRJNA509910-su011_pre_rep2",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su011",
        "adc_sample_id": "su011_pre_rep2",
        "adc_study_group_description": "pre treatment",
        "participant": "dc9cb12c-47ef-4f97-8a68-85616361bd98"
      },
      "LifeEvent_Specimen_su011_su011_pre_rep2": {
        "akc_id": "51a08373-ae95-4a5c-80be-1458d9f6681d",
        "participant": "dc9cb12c-47ef-4f97-8a68-85616361bd98",
        "t0_event": "pre treatment",
        "start": 13,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su012_su012_post": {
        "akc_id": "f33517d7-4a95-4197-87f0-d6058bf4170d",
        "participant": "69505dce-ee19-48c3-9c31-82fadfa36f0c"
      },
      "LifeEvent_ImmuneExposure_su012_su012_post": {
        "akc_id": "6da8b27a-61e8-4dbe-893f-08c0ab2187ae",
        "participant": "69505dce-ee19-48c3-9c31-82fadfa36f0c"
      },
      "LifeEvent_Specimen_su012_su012_post": {
        "akc_id": "9040c1d6-83ab-4d0c-9bb3-4c2ff99a4b03",
        "participant": "69505dce-ee19-48c3-9c31-82fadfa36f0c",
        "t0_event": "post treatment",
        "start": 21,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su012_su012_pre": {
        "akc_id": "fc909532-23f2-4e5e-bcef-edb1b96ee918",
        "adc_link_tag": "LifeEvent_Participant_su012_su012_pre",
        "adc_repertoire_id": "PRJNA509910-su012_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su012_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su012_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su012",
        "adc_sample_id": "su012_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "69505dce-ee19-48c3-9c31-82fadfa36f0c"
      },
      "LifeEvent_Specimen_su012_su012_pre": {
        "akc_id": "dfb021f2-8a96-457f-b795-4ac7acc01ee9",
        "participant": "69505dce-ee19-48c3-9c31-82fadfa36f0c",
        "t0_event": "pre treatment",
        "start": 0,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su013_su013_post": {
        "akc_id": "c2eab91a-4e77-437c-a161-6e214017069f",
        "participant": "34ef3424-65f7-47c3-af37-a5dcc98e819a"
      },
      "LifeEvent_ImmuneExposure_su013_su013_post": {
        "akc_id": "30085407-0579-45b7-8fc7-6bdf0e4806b7",
        "participant": "34ef3424-65f7-47c3-af37-a5dcc98e819a"
      },
      "LifeEvent_Specimen_su013_su013_post": {
        "akc_id": "383d0144-2255-421c-98c7-2ae6583adddb",
        "participant": "34ef3424-65f7-47c3-af37-a5dcc98e819a",
        "t0_event": "post treatment",
        "start": 49,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su013_su013_pre": {
        "akc_id": "769ec085-3017-49de-b84d-9c6fe037c6e8",
        "adc_link_tag": "LifeEvent_Participant_su013_su013_pre",
        "adc_repertoire_id": "PRJNA509910-su013_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su013_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su013_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su013",
        "adc_sample_id": "su013_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "34ef3424-65f7-47c3-af37-a5dcc98e819a"
      },
      "LifeEvent_Specimen_su013_su013_pre": {
        "akc_id": "6d01a0b1-95a7-45af-ac16-58cdaae066f5",
        "participant": "34ef3424-65f7-47c3-af37-a5dcc98e819a",
        "t0_event": "pre treatment",
        "start": 7,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su014_su014_post": {
        "akc_id": "bad9075d-544e-476e-af7c-3cee4295ff4f",
        "participant": "ce344616-927a-4a86-8907-b5f7c1d4d7a7"
      },
      "LifeEvent_ImmuneExposure_su014_su014_post": {
        "akc_id": "dad574bb-b1f3-43db-bfb9-29efd4addf3b",
        "participant": "ce344616-927a-4a86-8907-b5f7c1d4d7a7"
      },
      "LifeEvent_Specimen_su014_su014_post": {
        "akc_id": "3749a4c6-5ca5-4977-bef1-7f720c5ffda6",
        "participant": "ce344616-927a-4a86-8907-b5f7c1d4d7a7",
        "t0_event": "post treatment",
        "start": 28,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      },
      "LifeEvent_Participant_su014_su014_pre": {
        "akc_id": "c23c9c41-998c-4cee-bcf1-d266a9492bf8",
        "adc_link_tag": "LifeEvent_Participant_su014_su014_pre",
        "adc_repertoire_id": "PRJNA509910-su014_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su014_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su014_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su014",
        "adc_sample_id": "su014_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "ce344616-927a-4a86-8907-b5f7c1d4d7a7"
      },
      "LifeEvent_Specimen_su014_su014_pre": {
        "akc_id": "324c42f3-f26d-4f6b-bceb-4c9af38c5e9b",
        "participant": "ce344616-927a-4a86-8907-b5f7c1d4d7a7",
        "t0_event": "pre treatment",
        "start": 0,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        }
      }
    },
    "immune_exposures": {
      "ImmuneExposure_su001_DOID:2513": {
        "akc_id": "210c7703-51b3-4d7c-b385-b6e4086928b8",
        "life_event": "596b1c99-2069-4ff2-9c36-7ce9414c4674",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic"
      },
      "ImmuneExposure_su002_DOID:2513": {
        "akc_id": "344d83e2-f35d-4b13-917b-fa2459f10b87",
        "life_event": "8c4abb7f-72af-4a10-be76-3bcc73b8b299",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic"
      },
      "ImmuneExposure_su003_DOID:2513": {
        "akc_id": "c8fd72ab-130f-42a0-b845-ff4d3efce5d0",
        "life_event": "68a9c9f2-493b-4580-88dd-c525b14c85e5",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic"
      },
      "ImmuneExposure_su004_DOID:2513": {
        "akc_id": "8549d5a8-065e-4b09-bf19-192313350474",
        "life_event": "2a4742ad-2440-4f7d-97a0-7ea149ea9fe7",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic"
      },
      "ImmuneExposure_su005_DOID:2513": {
        "akc_id": "cd1dfd23-2547-4bea-8857-5c08ccfd7336",
        "life_event": "b2a58dad-f807-4841-ae06-6f2024ab06b3",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic"
      },
      "ImmuneExposure_su006_DOID:2513": {
        "akc_id": "f6d92bc3-be46-4171-9ce3-e048c43939f5",
        "life_event": "1a121e91-caee-431f-a845-2f5bad5e8f83",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic"
      },
      "ImmuneExposure_su007_DOID:2513": {
        "akc_id": "68319810-4780-4ec3-acc8-1e7a2bb224f3",
        "life_event": "a7d881f0-d3a4-4f3c-8db1-93b5f185b23d",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic"
      },
      "ImmuneExposure_su008_DOID:2513": {
        "akc_id": "b6072326-bf0a-42db-bf4a-eb4044a18fbb",
        "life_event": "8a28f877-96f0-4f13-9d0b-96c6b438b049",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic"
      },
      "ImmuneExposure_su009_DOID:2513": {
        "akc_id": "32251298-4c35-4675-85c4-2255d1e8aa13",
        "life_event": "d94ad7a4-84b7-4a44-87f9-c5bac367f8f2",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic"
      },
      "ImmuneExposure_su010_DOID:2513": {
        "akc_id": "b17ea356-3957-453e-8fb0-9bf3580af318",
        "life_event": "51f0eb13-b855-4705-83a6-43c338a8bcf1",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic"
      },
      "ImmuneExposure_su010_DOID:1749": {
        "akc_id": "422056c0-7dd0-4221-9e20-d432002e2246",
        "life_event": "0d05213e-be31-4315-8a22-3fa6bfe68306",
        "disease": {
          "label": "squamous cell carcinoma",
          "id": "DOID:1749"
        },
        "disease_stage": "advanced/metastatic"
      },
      "ImmuneExposure_su011_DOID:1749": {
        "akc_id": "c36c3dde-1856-4627-85de-dc48e6680bbf",
        "life_event": "90868a68-72eb-4868-a49c-b179c20ff1c9",
        "disease": {
          "label": "squamous cell carcinoma",
          "id": "DOID:1749"
        },
        "disease_stage": "advanced/metastatic"
      },
      "ImmuneExposure_su012_DOID:2513": {
        "akc_id": "54eae96b-9f2b-4131-9513-befb966cbcbd",
        "life_event": "6da8b27a-61e8-4dbe-893f-08c0ab2187ae",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic"
      },
      "ImmuneExposure_su013_DOID:1749": {
        "akc_id": "2831685f-932d-4c2b-83ed-eb2792af825f",
        "life_event": "30085407-0579-45b7-8fc7-6bdf0e4806b7",
        "disease": {
          "label": "squamous cell carcinoma",
          "id": "DOID:1749"
        },
        "disease_stage": "advanced/metastatic"
      },
      "ImmuneExposure_su014_DOID:1749": {
        "akc_id": "1eac89df-db33-4c31-a328-b50748efd650",
        "life_event": "dad574bb-b1f3-43db-bfb9-29efd4addf3b",
        "disease": {
          "label": "squamous cell carcinoma",
          "id": "DOID:1749"
        },
        "disease_stage": "advanced/metastatic"
      }
    },
    "specimens": {
      "Specimen_su001_su001_post": {
        "akc_id": "3c45c787-a3e9-483d-9090-3c28b2a281ae",
        "name": "su001_post",
        "life_event": "fa218a6f-ecc5-4c91-bb9a-89475006d5af",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "arm skin",
          "id": "UBERON:0002427"
        }
      },
      "Specimen_su001_su001_pre1": {
        "akc_id": "6097580c-4b2a-4be3-af29-dfe106b93ea5",
        "name": "su001_pre1",
        "life_event": "83ad8e44-f846-46fa-ae39-e5d9bf31a87a",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "arm skin",
          "id": "UBERON:0002427"
        }
      },
      "Specimen_su001_su001_pre2": {
        "akc_id": "ff6a5174-a59d-4fcd-a8a1-25b12e3f4145",
        "name": "su001_pre2",
        "life_event": "55fbe8e4-2791-445b-8275-e26ca632b035",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "arm skin",
          "id": "UBERON:0002427"
        }
      },
      "Specimen_su002_su002_post": {
        "akc_id": "eafe58d1-0f9d-4cb7-bafd-c6c1f6ec01f9",
        "name": "su002_post",
        "life_event": "2847db36-49bc-4ff8-a797-0ccd82b1d36d",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "nose skin",
          "id": "UBERON:0015476"
        }
      },
      "Specimen_su002_su002_pre": {
        "akc_id": "7c0cfdd4-06ad-4125-9427-2ca65edbca6e",
        "name": "su002_pre",
        "life_event": "c8a232db-32a8-412f-a5e4-5d6df3c37b3f",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "nose skin",
          "id": "UBERON:0015476"
        }
      },
      "Specimen_su003_su003_post": {
        "akc_id": "b8bdbd34-0d0c-4a3d-a027-1b1e7fca9dac",
        "name": "su003_post",
        "life_event": "073c5003-280b-44c0-b918-852b28ab84e4",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of chest",
          "id": "UBERON:0001868"
        }
      },
      "Specimen_su003_su003_pre": {
        "akc_id": "4a62b2e5-7c83-47ad-8ef2-89e99f5c6376",
        "name": "su003_pre",
        "life_event": "39ed73a5-1251-4672-bb22-86d0c1843d3c",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "arm skin",
          "id": "UBERON:0002427"
        }
      },
      "Specimen_su004_su004_post": {
        "akc_id": "bb0762c1-83d2-4719-a186-fdf56a48bf50",
        "name": "su004_post",
        "life_event": "5f72cf78-1000-4db7-afd1-f7d3409e1d06",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of knee",
          "id": "UBERON:0001510"
        }
      },
      "Specimen_su004_su004_pre": {
        "akc_id": "84eead8e-605f-4538-91dd-c08f3daf4443",
        "name": "su004_pre",
        "life_event": "e000e37d-2729-4549-95ad-58e8c2c16d91",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of knee",
          "id": "UBERON:0001510"
        }
      },
      "Specimen_su005_su005_post": {
        "akc_id": "42e9e9bc-aa09-49bb-b681-97ccce06100e",
        "name": "su005_post",
        "life_event": "89f2ebcd-d221-408e-877c-fb9f1728bb31",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of external ear",
          "id": "UBERON:0001459"
        }
      },
      "Specimen_su005_su005_pre": {
        "akc_id": "8e896530-8186-496d-b937-13e152a11a60",
        "name": "su005_pre",
        "life_event": "f0d0a291-6ff3-4f64-9347-64c96183c19d",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of external ear",
          "id": "UBERON:0001459"
        }
      },
      "Specimen_su006_su006_post": {
        "akc_id": "03ded81a-a5a0-4eac-9d6d-0f76e98e8322",
        "name": "su006_post",
        "life_event": "2680a47a-c4a0-46b7-bf71-c6cdc6e147ae",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of neck",
          "id": "UBERON:0001417"
        }
      },
      "Specimen_su006_su006_pre": {
        "akc_id": "97273758-d2f8-4341-a421-674e8ec8cfc7",
        "name": "su006_pre",
        "life_event": "cfd11d04-4c01-4e18-a0a8-47007c2d36cd",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of neck",
          "id": "UBERON:0001417"
        }
      },
      "Specimen_su007_su007_post": {
        "akc_id": "c4772edb-4657-41ab-8686-a8c63f48181d",
        "name": "su007_post",
        "life_event": "f623ca5d-36c3-4f03-8586-1adc60d2e010",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of cheek",
          "id": "UBERON:0008803"
        }
      },
      "Specimen_su007_su007_pre": {
        "akc_id": "713165ec-b871-45a2-bf4e-8a94a188b4b5",
        "name": "su007_pre",
        "life_event": "98abbd60-a148-40c3-b1cb-68fe49b1ef8d",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of cheek",
          "id": "UBERON:0008803"
        }
      },
      "Specimen_su008_su008_post": {
        "akc_id": "ce5f0e9d-168e-4e92-bed1-130ac7c567cd",
        "name": "su008_post",
        "life_event": "18b82bec-78f2-422d-9683-855b0f977fbb",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "arm skin",
          "id": "UBERON:0002427"
        }
      },
      "Specimen_su008_su008_pre": {
        "akc_id": "91d127ff-e71a-48b5-b640-71d3d4fd841e",
        "name": "su008_pre",
        "life_event": "b9c6874b-f185-434e-a7ba-3612da1612af",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "arm skin",
          "id": "UBERON:0002427"
        }
      },
      "Specimen_su009_su009_post": {
        "akc_id": "457d6780-148c-41be-ae42-80d074d9e2cc",
        "name": "su009_post",
        "life_event": "31478d05-52e0-49f1-b76d-ad996d4db8e7",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of forehead",
          "id": "UBERON:0016475"
        }
      },
      "Specimen_su009_su009_pre": {
        "akc_id": "c96e4ef1-eada-4efa-b9a1-f18c0f3fbea9",
        "name": "su009_pre",
        "life_event": "2276e9c4-7e98-4ca6-a513-786d9a67f202",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of forehead",
          "id": "UBERON:0016475"
        }
      },
      "Specimen_su010_su010_post_BCC": {
        "akc_id": "feaf45db-0897-4ec3-be06-c9c5339bf144",
        "name": "su010_post_BCC",
        "life_event": "36ea152e-2e31-4cb0-bcfa-9f489d260496",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "lower leg skin",
          "id": "UBERON:0004264"
        }
      },
      "Specimen_su010_su010_post_SCC": {
        "akc_id": "8fca3d1e-3e21-436b-a687-d87a4d5a1145",
        "name": "su010_post_SCC",
        "life_event": "2b19bacc-7a2d-450e-ada9-d023aaf75f74",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of external ear",
          "id": "UBERON:0001459"
        }
      },
      "Specimen_su010_su010_post_SCC_CD39": {
        "akc_id": "9a5c7eb0-45da-4eac-a7dd-ff119a11f7c5",
        "name": "su010_post_SCC_CD39",
        "life_event": "eccc1d81-cdb0-4ed5-9776-6c201c23015e",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of external ear",
          "id": "UBERON:0001459"
        }
      },
      "Specimen_su010_su010_pre_BCC": {
        "akc_id": "f3bd4408-e8a8-4d19-9ea9-22b823e69f8f",
        "name": "su010_pre_BCC",
        "life_event": "bddd3089-6bd5-4a4a-81e9-35a336e6484b",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "lower leg skin",
          "id": "UBERON:0004264"
        }
      },
      "Specimen_su010_su010_pre_SCC_rep1": {
        "akc_id": "c237d39b-5b5f-41e7-bcdc-234c1c3660b0",
        "name": "su010_pre_SCC_rep1",
        "life_event": "9625fcfb-fbb8-4f8d-b899-a1e92e864a05",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of external ear",
          "id": "UBERON:0001459"
        }
      },
      "Specimen_su010_su010_pre_SCC_rep2": {
        "akc_id": "32da32b8-8270-4ae4-acf5-0ec5735f3f8d",
        "name": "su010_pre_SCC_rep2",
        "life_event": "f8272266-8ea8-45bd-82f3-0be8548fffc7",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of external ear",
          "id": "UBERON:0001459"
        }
      },
      "Specimen_su011_su011_post": {
        "akc_id": "5f8bc767-d12d-433c-85ba-780e8838f958",
        "name": "su011_post",
        "life_event": "135e7043-7822-4401-b11f-08b924ba4d9c",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of scalp",
          "id": "UBERON:8300000"
        }
      },
      "Specimen_su011_su011_pre_rep1": {
        "akc_id": "34187e77-b08b-4162-8e28-4bda70b1aaeb",
        "name": "su011_pre_rep1",
        "life_event": "d26617a1-818f-4f15-acee-db3ce98ef522",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of scalp",
          "id": "UBERON:8300000"
        }
      },
      "Specimen_su011_su011_pre_rep2": {
        "akc_id": "c5e742de-5ec5-4c01-912e-f75e5e0efdf1",
        "name": "su011_pre_rep2",
        "life_event": "51a08373-ae95-4a5c-80be-1458d9f6681d",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of scalp",
          "id": "UBERON:8300000"
        }
      },
      "Specimen_su012_su012_post": {
        "akc_id": "a138fb4b-b5c7-4f32-bbb4-a085eafe0576",
        "name": "su012_post",
        "life_event": "9040c1d6-83ab-4d0c-9bb3-4c2ff99a4b03",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of cheek",
          "id": "UBERON:0008803"
        }
      },
      "Specimen_su012_su012_pre": {
        "akc_id": "0b47e42e-5035-427f-8d24-4d4a39da1af9",
        "name": "su012_pre",
        "life_event": "dfb021f2-8a96-457f-b795-4ac7acc01ee9",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of cheek",
          "id": "UBERON:0008803"
        }
      },
      "Specimen_su013_su013_post": {
        "akc_id": "e3ed0e16-0481-421f-bfd0-4bfabe9df6d9",
        "name": "su013_post",
        "life_event": "383d0144-2255-421c-98c7-2ae6583adddb",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of scalp",
          "id": "UBERON:8300000"
        }
      },
      "Specimen_su013_su013_pre": {
        "akc_id": "2e8792e2-2504-4656-83a5-97959b805206",
        "name": "su013_pre",
        "life_event": "6d01a0b1-95a7-45af-ac16-58cdaae066f5",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of scalp",
          "id": "UBERON:8300000"
        }
      },
      "Specimen_su014_su014_post": {
        "akc_id": "934e884a-1c43-4e30-b12c-33682ab639b9",
        "name": "su014_post",
        "life_event": "3749a4c6-5ca5-4977-bef1-7f720c5ffda6",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of neck",
          "id": "UBERON:0001417"
        }
      },
      "Specimen_su014_su014_pre": {
        "akc_id": "41bb4eeb-dea3-406f-bb06-8f41283c5e3e",
        "name": "su014_pre",
        "life_event": "324c42f3-f26d-4f6b-bceb-4c9af38c5e9b",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of neck",
          "id": "UBERON:0001417"
        }
      }
    },
    "specimen_processings": {
      "CellIsolationProcessing_su001_su001_post_PRJNA509910-su001_post-TRA": {
        "akc_id": "0030f799-7421-4d28-8840-7153d4c48d09",
        "specimen": "3c45c787-a3e9-483d-9090-3c28b2a281ae",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3773,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su001_su001_post_PRJNA509910-su001_post-TRA": {
        "akc_id": "57b2ee06-784d-45b0-baa0-7769a10405ca",
        "specimen": "3c45c787-a3e9-483d-9090-3c28b2a281ae",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su001_su001_post_PRJNA509910-su001_post-TRA": {
        "akc_id": "43ddebdc-d325-45af-9c90-90de9621be34",
        "specimen": "3c45c787-a3e9-483d-9090-3c28b2a281ae",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su001_su001_post_PRJNA509910-su001_post-TRB": {
        "akc_id": "b868379f-4ac9-47b0-9a2b-ccb755fbe30d",
        "specimen": "3c45c787-a3e9-483d-9090-3c28b2a281ae",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3773,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su001_su001_post_PRJNA509910-su001_post-TRB": {
        "akc_id": "f222cbb9-922c-4b33-8a14-9b630885ae1f",
        "specimen": "3c45c787-a3e9-483d-9090-3c28b2a281ae",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su001_su001_post_PRJNA509910-su001_post-TRB": {
        "akc_id": "b79793fb-0a93-4dd7-84ec-8466f6866ac7",
        "specimen": "3c45c787-a3e9-483d-9090-3c28b2a281ae",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su001_su001_post_PRJNA509910-su001_post-CELL": {
        "akc_id": "712124e3-eb15-48c0-b8b6-bf2104805a57",
        "specimen": "3c45c787-a3e9-483d-9090-3c28b2a281ae",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4915,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su001_su001_post_PRJNA509910-su001_post-CELL": {
        "akc_id": "01cfa57f-ad89-402f-8a21-3ffafc732b84",
        "specimen": "3c45c787-a3e9-483d-9090-3c28b2a281ae",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su001_su001_post_PRJNA509910-su001_post-CELL": {
        "akc_id": "bc32c81b-5cfe-4fb7-bf7f-e57fc62d617b",
        "specimen": "3c45c787-a3e9-483d-9090-3c28b2a281ae",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su001_su001_post_PRJNA509910-su001_post-TRB-CLONE": {
        "akc_id": "10dec426-02ae-4572-b40e-9501cad6f253",
        "specimen": "3c45c787-a3e9-483d-9090-3c28b2a281ae",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3773,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su001_su001_post_PRJNA509910-su001_post-TRB-CLONE": {
        "akc_id": "5c340162-4e9c-4b38-8f29-c0d8509a9f25",
        "specimen": "3c45c787-a3e9-483d-9090-3c28b2a281ae",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su001_su001_post_PRJNA509910-su001_post-TRB-CLONE": {
        "akc_id": "2bf1105a-b2c7-4798-8841-86f020d82dae",
        "specimen": "3c45c787-a3e9-483d-9090-3c28b2a281ae",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su001_su001_pre1_PRJNA509910-su001_pre1-TRA": {
        "akc_id": "580166b2-73b6-452c-ba91-413a02ddb19f",
        "specimen": "6097580c-4b2a-4be3-af29-dfe106b93ea5",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 700,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su001_su001_pre1_PRJNA509910-su001_pre1-TRA": {
        "akc_id": "137121e0-59bb-43bd-9d00-57702495bbf5",
        "specimen": "6097580c-4b2a-4be3-af29-dfe106b93ea5",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su001_su001_pre1_PRJNA509910-su001_pre1-TRA": {
        "akc_id": "862e1054-857d-4ef9-984e-1704855e4faf",
        "specimen": "6097580c-4b2a-4be3-af29-dfe106b93ea5",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su001_su001_pre1_PRJNA509910-su001_pre1-TRB": {
        "akc_id": "6612b207-0d69-48a6-8d60-785fd927d430",
        "specimen": "6097580c-4b2a-4be3-af29-dfe106b93ea5",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 700,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su001_su001_pre1_PRJNA509910-su001_pre1-TRB": {
        "akc_id": "15b141e2-0a6d-4f91-a0c3-cf088c9ed8a3",
        "specimen": "6097580c-4b2a-4be3-af29-dfe106b93ea5",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su001_su001_pre1_PRJNA509910-su001_pre1-TRB": {
        "akc_id": "b60f8a95-0c6f-4c9b-bb8f-8eb19d494f24",
        "specimen": "6097580c-4b2a-4be3-af29-dfe106b93ea5",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su001_su001_pre1_PRJNA509910-su001_pre1-CELL": {
        "akc_id": "f32fa997-0f32-464a-88a7-e9721b115683",
        "specimen": "6097580c-4b2a-4be3-af29-dfe106b93ea5",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 975,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su001_su001_pre1_PRJNA509910-su001_pre1-CELL": {
        "akc_id": "0a6fdb77-ea60-4c81-b571-a15812513956",
        "specimen": "6097580c-4b2a-4be3-af29-dfe106b93ea5",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su001_su001_pre1_PRJNA509910-su001_pre1-CELL": {
        "akc_id": "0435f755-af28-496a-8d3c-9e5a21e3c297",
        "specimen": "6097580c-4b2a-4be3-af29-dfe106b93ea5",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su001_su001_pre1_PRJNA509910-su001_pre1-TRB-CLONE": {
        "akc_id": "f8925b85-9f47-467d-91d6-255e0bd71bc1",
        "specimen": "6097580c-4b2a-4be3-af29-dfe106b93ea5",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 700,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su001_su001_pre1_PRJNA509910-su001_pre1-TRB-CLONE": {
        "akc_id": "ea9bd4c7-5bde-4f83-b07e-9e9cdae96056",
        "specimen": "6097580c-4b2a-4be3-af29-dfe106b93ea5",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su001_su001_pre1_PRJNA509910-su001_pre1-TRB-CLONE": {
        "akc_id": "7dab3087-fd08-4a3a-9873-9aa9210864a4",
        "specimen": "6097580c-4b2a-4be3-af29-dfe106b93ea5",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su001_su001_pre2_PRJNA509910-su001_pre2-TRA": {
        "akc_id": "6d98b987-b8c6-4378-a916-7f2616281f55",
        "specimen": "ff6a5174-a59d-4fcd-a8a1-25b12e3f4145",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 106,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su001_su001_pre2_PRJNA509910-su001_pre2-TRA": {
        "akc_id": "45645a3f-e06a-4b3e-b574-b87933c32798",
        "specimen": "ff6a5174-a59d-4fcd-a8a1-25b12e3f4145",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su001_su001_pre2_PRJNA509910-su001_pre2-TRA": {
        "akc_id": "a779c888-acc9-4e56-8954-4a497b9bcf4f",
        "specimen": "ff6a5174-a59d-4fcd-a8a1-25b12e3f4145",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su001_su001_pre2_PRJNA509910-su001_pre2-TRB": {
        "akc_id": "5eb9331c-ad3b-4658-a297-139eca4d1d3c",
        "specimen": "ff6a5174-a59d-4fcd-a8a1-25b12e3f4145",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 106,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su001_su001_pre2_PRJNA509910-su001_pre2-TRB": {
        "akc_id": "d17783e1-578f-4954-a0b0-e4e076b0cc4f",
        "specimen": "ff6a5174-a59d-4fcd-a8a1-25b12e3f4145",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su001_su001_pre2_PRJNA509910-su001_pre2-TRB": {
        "akc_id": "443eb734-81ee-430e-a569-7898d049cb17",
        "specimen": "ff6a5174-a59d-4fcd-a8a1-25b12e3f4145",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su001_su001_pre2_PRJNA509910-su001_pre2-CELL": {
        "akc_id": "51d4050e-4a21-4aa9-8911-57edc69a843e",
        "specimen": "ff6a5174-a59d-4fcd-a8a1-25b12e3f4145",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 192,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su001_su001_pre2_PRJNA509910-su001_pre2-CELL": {
        "akc_id": "a546da4b-f9d4-4f5d-a5f0-9ab81a3ac9bc",
        "specimen": "ff6a5174-a59d-4fcd-a8a1-25b12e3f4145",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su001_su001_pre2_PRJNA509910-su001_pre2-CELL": {
        "akc_id": "bc0338ff-ce51-485b-8046-a386242d1e39",
        "specimen": "ff6a5174-a59d-4fcd-a8a1-25b12e3f4145",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su001_su001_pre2_PRJNA509910-su001_pre2-TRB-CLONE": {
        "akc_id": "a88ea0a5-3e19-4f7d-b809-8cf441a2e57e",
        "specimen": "ff6a5174-a59d-4fcd-a8a1-25b12e3f4145",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 106,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su001_su001_pre2_PRJNA509910-su001_pre2-TRB-CLONE": {
        "akc_id": "a0aa5fcb-569a-45d3-bc91-829af1d3f8a5",
        "specimen": "ff6a5174-a59d-4fcd-a8a1-25b12e3f4145",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su001_su001_pre2_PRJNA509910-su001_pre2-TRB-CLONE": {
        "akc_id": "c0a73456-4b03-449a-a8fd-f4373d899158",
        "specimen": "ff6a5174-a59d-4fcd-a8a1-25b12e3f4145",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su002_su002_post_PRJNA509910-su002_post-TRA": {
        "akc_id": "9204b30f-12ce-4b1a-9aa9-ca00facc4bb0",
        "specimen": "eafe58d1-0f9d-4cb7-bafd-c6c1f6ec01f9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 147,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su002_su002_post_PRJNA509910-su002_post-TRA": {
        "akc_id": "ba38b598-1e33-4b35-aec8-5908355c5ca7",
        "specimen": "eafe58d1-0f9d-4cb7-bafd-c6c1f6ec01f9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su002_su002_post_PRJNA509910-su002_post-TRA": {
        "akc_id": "04a5ae8e-f05c-457f-9765-3eb13773ccee",
        "specimen": "eafe58d1-0f9d-4cb7-bafd-c6c1f6ec01f9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su002_su002_post_PRJNA509910-su002_post-TRB": {
        "akc_id": "24abcb61-eaa4-4582-b68a-96dc103edd50",
        "specimen": "eafe58d1-0f9d-4cb7-bafd-c6c1f6ec01f9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 147,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su002_su002_post_PRJNA509910-su002_post-TRB": {
        "akc_id": "c10bff18-90bc-49f8-971b-7747d9c45f17",
        "specimen": "eafe58d1-0f9d-4cb7-bafd-c6c1f6ec01f9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su002_su002_post_PRJNA509910-su002_post-TRB": {
        "akc_id": "d3fd98b7-3298-4a53-ba54-dc3f629abc14",
        "specimen": "eafe58d1-0f9d-4cb7-bafd-c6c1f6ec01f9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su002_su002_post_PRJNA509910-su002_post-CELL": {
        "akc_id": "19c3c356-d4e7-4cb0-9afe-488fc5095ab6",
        "specimen": "eafe58d1-0f9d-4cb7-bafd-c6c1f6ec01f9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 195,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su002_su002_post_PRJNA509910-su002_post-CELL": {
        "akc_id": "57d2699e-db9b-43f5-9869-3f91a9c801b1",
        "specimen": "eafe58d1-0f9d-4cb7-bafd-c6c1f6ec01f9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su002_su002_post_PRJNA509910-su002_post-CELL": {
        "akc_id": "9b99fb4a-9f3e-4fd4-bfe4-f30c4458b5a7",
        "specimen": "eafe58d1-0f9d-4cb7-bafd-c6c1f6ec01f9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su002_su002_post_PRJNA509910-su002_post-TRB-CLONE": {
        "akc_id": "a402acc0-7a31-4cbb-bbd8-d2f36a5253f1",
        "specimen": "eafe58d1-0f9d-4cb7-bafd-c6c1f6ec01f9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 147,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su002_su002_post_PRJNA509910-su002_post-TRB-CLONE": {
        "akc_id": "aa43b197-62e9-4211-9295-95ad092964d5",
        "specimen": "eafe58d1-0f9d-4cb7-bafd-c6c1f6ec01f9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su002_su002_post_PRJNA509910-su002_post-TRB-CLONE": {
        "akc_id": "31b84776-ef69-4614-bbbe-c7a22f68276b",
        "specimen": "eafe58d1-0f9d-4cb7-bafd-c6c1f6ec01f9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su002_su002_pre_PRJNA509910-su002_pre-TRA": {
        "akc_id": "a8831f40-1ebd-47c7-91b2-dd3e0460fc2d",
        "specimen": "7c0cfdd4-06ad-4125-9427-2ca65edbca6e",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 81,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su002_su002_pre_PRJNA509910-su002_pre-TRA": {
        "akc_id": "a0f6c977-156d-4103-99c9-a096741507ce",
        "specimen": "7c0cfdd4-06ad-4125-9427-2ca65edbca6e",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su002_su002_pre_PRJNA509910-su002_pre-TRA": {
        "akc_id": "4c9f8cee-ab82-4115-8419-a5a0f5b4e099",
        "specimen": "7c0cfdd4-06ad-4125-9427-2ca65edbca6e",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su002_su002_pre_PRJNA509910-su002_pre-TRB": {
        "akc_id": "7358a4fb-1c1e-4a3e-abe3-6a2f7d2bc032",
        "specimen": "7c0cfdd4-06ad-4125-9427-2ca65edbca6e",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 81,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su002_su002_pre_PRJNA509910-su002_pre-TRB": {
        "akc_id": "c771fa4e-486c-407e-bac8-d837b32df17f",
        "specimen": "7c0cfdd4-06ad-4125-9427-2ca65edbca6e",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su002_su002_pre_PRJNA509910-su002_pre-TRB": {
        "akc_id": "c9f9f144-3b1e-4f61-99c4-6603f5b7bcf2",
        "specimen": "7c0cfdd4-06ad-4125-9427-2ca65edbca6e",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su002_su002_pre_PRJNA509910-su002_pre-CELL": {
        "akc_id": "7c344ead-589e-420d-8be7-5b3fa5664116",
        "specimen": "7c0cfdd4-06ad-4125-9427-2ca65edbca6e",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 162,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su002_su002_pre_PRJNA509910-su002_pre-CELL": {
        "akc_id": "196513d6-ccd1-41d1-92c8-08e59a58293f",
        "specimen": "7c0cfdd4-06ad-4125-9427-2ca65edbca6e",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su002_su002_pre_PRJNA509910-su002_pre-CELL": {
        "akc_id": "21ad20d1-cf06-481f-b94e-ab8012094fa5",
        "specimen": "7c0cfdd4-06ad-4125-9427-2ca65edbca6e",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su002_su002_pre_PRJNA509910-su002_pre-TRB-CLONE": {
        "akc_id": "95537d4f-b341-4581-b3bd-808f322ea229",
        "specimen": "7c0cfdd4-06ad-4125-9427-2ca65edbca6e",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 81,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su002_su002_pre_PRJNA509910-su002_pre-TRB-CLONE": {
        "akc_id": "cf0b7e35-a7db-41b2-93f1-24b172443cba",
        "specimen": "7c0cfdd4-06ad-4125-9427-2ca65edbca6e",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su002_su002_pre_PRJNA509910-su002_pre-TRB-CLONE": {
        "akc_id": "6ed9fd3f-7e92-4474-9582-4c82b24cf1b1",
        "specimen": "7c0cfdd4-06ad-4125-9427-2ca65edbca6e",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su003_su003_post_PRJNA509910-su003_post-TRA": {
        "akc_id": "c34fe55a-69fa-4e54-ae48-dc2356cce171",
        "specimen": "b8bdbd34-0d0c-4a3d-a027-1b1e7fca9dac",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 114,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su003_su003_post_PRJNA509910-su003_post-TRA": {
        "akc_id": "5b924d43-b086-4315-819a-c12071ac7898",
        "specimen": "b8bdbd34-0d0c-4a3d-a027-1b1e7fca9dac",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su003_su003_post_PRJNA509910-su003_post-TRA": {
        "akc_id": "644e7c6c-089d-42cf-8a78-69411036d0c0",
        "specimen": "b8bdbd34-0d0c-4a3d-a027-1b1e7fca9dac",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su003_su003_post_PRJNA509910-su003_post-TRB": {
        "akc_id": "8b997c42-ce17-4cc0-9887-ac2d6822ea13",
        "specimen": "b8bdbd34-0d0c-4a3d-a027-1b1e7fca9dac",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 114,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su003_su003_post_PRJNA509910-su003_post-TRB": {
        "akc_id": "9cf98172-b19e-4096-924d-b66489144cf4",
        "specimen": "b8bdbd34-0d0c-4a3d-a027-1b1e7fca9dac",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su003_su003_post_PRJNA509910-su003_post-TRB": {
        "akc_id": "e67a52d9-d18b-4278-815d-eca2d7ef9031",
        "specimen": "b8bdbd34-0d0c-4a3d-a027-1b1e7fca9dac",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su003_su003_post_PRJNA509910-su003_post-CELL": {
        "akc_id": "a2cb780c-c3bd-40a2-a712-bd2cef9d6dd5",
        "specimen": "b8bdbd34-0d0c-4a3d-a027-1b1e7fca9dac",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 262,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su003_su003_post_PRJNA509910-su003_post-CELL": {
        "akc_id": "818e3aac-de36-4c11-8b95-6dac29e2e1f6",
        "specimen": "b8bdbd34-0d0c-4a3d-a027-1b1e7fca9dac",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su003_su003_post_PRJNA509910-su003_post-CELL": {
        "akc_id": "51d44a16-eee6-4690-bec1-b5fab60a836d",
        "specimen": "b8bdbd34-0d0c-4a3d-a027-1b1e7fca9dac",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su003_su003_post_PRJNA509910-su003_post-TRB-CLONE": {
        "akc_id": "cd0feeb3-ac27-4807-820f-d0e2b4aaf8ce",
        "specimen": "b8bdbd34-0d0c-4a3d-a027-1b1e7fca9dac",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 114,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su003_su003_post_PRJNA509910-su003_post-TRB-CLONE": {
        "akc_id": "a10d803d-3363-4ff4-a2ee-cc5644698fd0",
        "specimen": "b8bdbd34-0d0c-4a3d-a027-1b1e7fca9dac",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su003_su003_post_PRJNA509910-su003_post-TRB-CLONE": {
        "akc_id": "a2951e29-01e9-4c87-8ac4-74282f1ade99",
        "specimen": "b8bdbd34-0d0c-4a3d-a027-1b1e7fca9dac",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su003_su003_pre_PRJNA509910-su003_pre-TRA": {
        "akc_id": "5d1a6ff1-2eb9-46d0-8b7e-1dc17fd4ba33",
        "specimen": "4a62b2e5-7c83-47ad-8ef2-89e99f5c6376",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 73,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su003_su003_pre_PRJNA509910-su003_pre-TRA": {
        "akc_id": "5658197e-6d78-4ab3-8033-04ad9a38e232",
        "specimen": "4a62b2e5-7c83-47ad-8ef2-89e99f5c6376",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su003_su003_pre_PRJNA509910-su003_pre-TRA": {
        "akc_id": "1f226406-bdb4-47d2-9e72-71fea82ff5e8",
        "specimen": "4a62b2e5-7c83-47ad-8ef2-89e99f5c6376",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su003_su003_pre_PRJNA509910-su003_pre-TRB": {
        "akc_id": "4fc9f007-42b4-493e-832c-d9525fc2f583",
        "specimen": "4a62b2e5-7c83-47ad-8ef2-89e99f5c6376",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 73,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su003_su003_pre_PRJNA509910-su003_pre-TRB": {
        "akc_id": "3bffc789-992d-4daa-b982-2a3d8726de25",
        "specimen": "4a62b2e5-7c83-47ad-8ef2-89e99f5c6376",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su003_su003_pre_PRJNA509910-su003_pre-TRB": {
        "akc_id": "2a01bd8e-c7c0-414f-92f0-efb940f60433",
        "specimen": "4a62b2e5-7c83-47ad-8ef2-89e99f5c6376",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su003_su003_pre_PRJNA509910-su003_pre-CELL": {
        "akc_id": "735c5153-b58c-4539-8a5c-729a91bab0c1",
        "specimen": "4a62b2e5-7c83-47ad-8ef2-89e99f5c6376",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 329,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su003_su003_pre_PRJNA509910-su003_pre-CELL": {
        "akc_id": "7a7a909b-5e3c-46f6-85d9-419c88f17472",
        "specimen": "4a62b2e5-7c83-47ad-8ef2-89e99f5c6376",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su003_su003_pre_PRJNA509910-su003_pre-CELL": {
        "akc_id": "3feb3538-8fe8-4369-9bbb-da1eeb925840",
        "specimen": "4a62b2e5-7c83-47ad-8ef2-89e99f5c6376",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su003_su003_pre_PRJNA509910-su003_pre-TRB-CLONE": {
        "akc_id": "b24fdc05-7248-4f9f-94b3-f3b7cd68bee1",
        "specimen": "4a62b2e5-7c83-47ad-8ef2-89e99f5c6376",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 73,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su003_su003_pre_PRJNA509910-su003_pre-TRB-CLONE": {
        "akc_id": "e92f7576-351c-471b-bbe2-d0b39ace87fb",
        "specimen": "4a62b2e5-7c83-47ad-8ef2-89e99f5c6376",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su003_su003_pre_PRJNA509910-su003_pre-TRB-CLONE": {
        "akc_id": "b44fe1bb-66c1-4428-af7e-211dd20b3549",
        "specimen": "4a62b2e5-7c83-47ad-8ef2-89e99f5c6376",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su004_su004_post_PRJNA509910-su004_post-TRA": {
        "akc_id": "98a4807b-5a13-4bcb-b866-db6c72f2c3fe",
        "specimen": "bb0762c1-83d2-4719-a186-fdf56a48bf50",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 295,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su004_su004_post_PRJNA509910-su004_post-TRA": {
        "akc_id": "21c3f37a-8be9-4905-9b0d-9b9b8aa79845",
        "specimen": "bb0762c1-83d2-4719-a186-fdf56a48bf50",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su004_su004_post_PRJNA509910-su004_post-TRA": {
        "akc_id": "a3a8b660-6a31-487e-b895-694ea8b505af",
        "specimen": "bb0762c1-83d2-4719-a186-fdf56a48bf50",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su004_su004_post_PRJNA509910-su004_post-TRB": {
        "akc_id": "73cd932d-cbf9-4f7f-a698-2f7464c82c33",
        "specimen": "bb0762c1-83d2-4719-a186-fdf56a48bf50",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 295,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su004_su004_post_PRJNA509910-su004_post-TRB": {
        "akc_id": "bd48a7cc-bda9-4054-911a-368ed3609f32",
        "specimen": "bb0762c1-83d2-4719-a186-fdf56a48bf50",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su004_su004_post_PRJNA509910-su004_post-TRB": {
        "akc_id": "e9b7e0bc-cb21-4a35-9337-9cb032383524",
        "specimen": "bb0762c1-83d2-4719-a186-fdf56a48bf50",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su004_su004_post_PRJNA509910-su004_post-CELL": {
        "akc_id": "c9d8c825-6930-4bfd-ad2a-53d23c482213",
        "specimen": "bb0762c1-83d2-4719-a186-fdf56a48bf50",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 400,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su004_su004_post_PRJNA509910-su004_post-CELL": {
        "akc_id": "7b7d7b24-dd2e-4103-afde-a19f32d92d85",
        "specimen": "bb0762c1-83d2-4719-a186-fdf56a48bf50",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su004_su004_post_PRJNA509910-su004_post-CELL": {
        "akc_id": "c1ec6baa-8800-4a6b-820c-6b4f8465d0a3",
        "specimen": "bb0762c1-83d2-4719-a186-fdf56a48bf50",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su004_su004_post_PRJNA509910-su004_post-TRB-CLONE": {
        "akc_id": "d8a26633-6385-42c0-b80d-36ec49dfc83b",
        "specimen": "bb0762c1-83d2-4719-a186-fdf56a48bf50",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 295,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su004_su004_post_PRJNA509910-su004_post-TRB-CLONE": {
        "akc_id": "a5ce3d0e-fff4-4b17-b681-49bd0e7424e4",
        "specimen": "bb0762c1-83d2-4719-a186-fdf56a48bf50",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su004_su004_post_PRJNA509910-su004_post-TRB-CLONE": {
        "akc_id": "06ce9311-a82c-4f49-bc6f-7b097bf8f6c1",
        "specimen": "bb0762c1-83d2-4719-a186-fdf56a48bf50",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su004_su004_pre_PRJNA509910-su004_pre-TRA": {
        "akc_id": "6df922f0-f010-47b9-bc62-608fae13bceb",
        "specimen": "84eead8e-605f-4538-91dd-c08f3daf4443",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 471,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su004_su004_pre_PRJNA509910-su004_pre-TRA": {
        "akc_id": "eb1fa0c9-0ce1-40af-966d-af62aac0b26a",
        "specimen": "84eead8e-605f-4538-91dd-c08f3daf4443",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su004_su004_pre_PRJNA509910-su004_pre-TRA": {
        "akc_id": "1285f0df-22e5-4936-b6ae-b7f3fe44ab4d",
        "specimen": "84eead8e-605f-4538-91dd-c08f3daf4443",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su004_su004_pre_PRJNA509910-su004_pre-TRB": {
        "akc_id": "8b4387a7-51c9-47c9-8a06-d88a8d66b762",
        "specimen": "84eead8e-605f-4538-91dd-c08f3daf4443",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 471,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su004_su004_pre_PRJNA509910-su004_pre-TRB": {
        "akc_id": "cdf04654-34ad-4595-acc2-0a3039f44ca7",
        "specimen": "84eead8e-605f-4538-91dd-c08f3daf4443",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su004_su004_pre_PRJNA509910-su004_pre-TRB": {
        "akc_id": "69514ba6-47d2-453c-8668-419cbbcb7f7c",
        "specimen": "84eead8e-605f-4538-91dd-c08f3daf4443",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su004_su004_pre_PRJNA509910-su004_pre-CELL": {
        "akc_id": "200b8155-d9c7-4928-9b6f-90cc3bd0ca46",
        "specimen": "84eead8e-605f-4538-91dd-c08f3daf4443",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 661,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su004_su004_pre_PRJNA509910-su004_pre-CELL": {
        "akc_id": "169479f5-130a-4d8f-b70b-4231fcca4a18",
        "specimen": "84eead8e-605f-4538-91dd-c08f3daf4443",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su004_su004_pre_PRJNA509910-su004_pre-CELL": {
        "akc_id": "e9bd58f1-a52c-412d-a703-473868261b9f",
        "specimen": "84eead8e-605f-4538-91dd-c08f3daf4443",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su004_su004_pre_PRJNA509910-su004_pre-TRB-CLONE": {
        "akc_id": "866d9a31-3d6f-4798-b79d-28f53062c14e",
        "specimen": "84eead8e-605f-4538-91dd-c08f3daf4443",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 471,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su004_su004_pre_PRJNA509910-su004_pre-TRB-CLONE": {
        "akc_id": "fe3ad690-ca2e-4583-9ab1-5b8267b15944",
        "specimen": "84eead8e-605f-4538-91dd-c08f3daf4443",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su004_su004_pre_PRJNA509910-su004_pre-TRB-CLONE": {
        "akc_id": "b6ad2341-a250-4317-9f0e-5d89d7b57024",
        "specimen": "84eead8e-605f-4538-91dd-c08f3daf4443",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su005_su005_post_PRJNA509910-su005_post-TRA": {
        "akc_id": "ae40b290-d474-4f17-b930-cd32fdeb0710",
        "specimen": "42e9e9bc-aa09-49bb-b681-97ccce06100e",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3859,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su005_su005_post_PRJNA509910-su005_post-TRA": {
        "akc_id": "fddb3a28-4501-41d2-8add-8e12a6e3305f",
        "specimen": "42e9e9bc-aa09-49bb-b681-97ccce06100e",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su005_su005_post_PRJNA509910-su005_post-TRA": {
        "akc_id": "b13fdf44-d413-4179-9832-eed951d02119",
        "specimen": "42e9e9bc-aa09-49bb-b681-97ccce06100e",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su005_su005_post_PRJNA509910-su005_post-TRB": {
        "akc_id": "9a2fb089-3040-4211-bfb1-cd5bee45c859",
        "specimen": "42e9e9bc-aa09-49bb-b681-97ccce06100e",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3859,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su005_su005_post_PRJNA509910-su005_post-TRB": {
        "akc_id": "85535ce7-85d0-464f-81e5-9d965b8b9ca0",
        "specimen": "42e9e9bc-aa09-49bb-b681-97ccce06100e",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su005_su005_post_PRJNA509910-su005_post-TRB": {
        "akc_id": "64f6c0ce-7256-43d9-8bec-7ad6db784bcb",
        "specimen": "42e9e9bc-aa09-49bb-b681-97ccce06100e",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su005_su005_post_PRJNA509910-su005_post-CELL": {
        "akc_id": "cd401be1-bf13-419d-bdc2-549ebc9cf820",
        "specimen": "42e9e9bc-aa09-49bb-b681-97ccce06100e",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4870,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su005_su005_post_PRJNA509910-su005_post-CELL": {
        "akc_id": "0493f6e7-a45a-42c9-a80f-10fbdd3358e0",
        "specimen": "42e9e9bc-aa09-49bb-b681-97ccce06100e",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su005_su005_post_PRJNA509910-su005_post-CELL": {
        "akc_id": "63c66066-0789-4dad-aa2a-94d493117f39",
        "specimen": "42e9e9bc-aa09-49bb-b681-97ccce06100e",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su005_su005_post_PRJNA509910-su005_post-TRB-CLONE": {
        "akc_id": "54f7b9cb-dbe8-4c72-af61-9dc0dfe809a2",
        "specimen": "42e9e9bc-aa09-49bb-b681-97ccce06100e",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3859,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su005_su005_post_PRJNA509910-su005_post-TRB-CLONE": {
        "akc_id": "9c725f10-c637-4d58-b066-6e18e179d7e8",
        "specimen": "42e9e9bc-aa09-49bb-b681-97ccce06100e",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su005_su005_post_PRJNA509910-su005_post-TRB-CLONE": {
        "akc_id": "d7b6769c-f51b-4ddc-9f39-ec7b83c69ad6",
        "specimen": "42e9e9bc-aa09-49bb-b681-97ccce06100e",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su005_su005_pre_PRJNA509910-su005_pre-TRA": {
        "akc_id": "d217a254-1b63-4198-a16c-f10e8a31eb31",
        "specimen": "8e896530-8186-496d-b937-13e152a11a60",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 839,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su005_su005_pre_PRJNA509910-su005_pre-TRA": {
        "akc_id": "848f0bb0-c262-4be5-bfce-0ce6cd41f55d",
        "specimen": "8e896530-8186-496d-b937-13e152a11a60",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su005_su005_pre_PRJNA509910-su005_pre-TRA": {
        "akc_id": "c94d9a85-ebe2-4e81-b7d8-fe65d37c5f51",
        "specimen": "8e896530-8186-496d-b937-13e152a11a60",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su005_su005_pre_PRJNA509910-su005_pre-TRB": {
        "akc_id": "3993102a-30bc-4cbf-850d-d968b802fa70",
        "specimen": "8e896530-8186-496d-b937-13e152a11a60",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 839,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su005_su005_pre_PRJNA509910-su005_pre-TRB": {
        "akc_id": "81334aa6-9727-4bb8-abba-9acf70a9a898",
        "specimen": "8e896530-8186-496d-b937-13e152a11a60",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su005_su005_pre_PRJNA509910-su005_pre-TRB": {
        "akc_id": "01fc4ff6-613b-4ca7-b88d-5d2bf864b841",
        "specimen": "8e896530-8186-496d-b937-13e152a11a60",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su005_su005_pre_PRJNA509910-su005_pre-CELL": {
        "akc_id": "6e2934e0-a5d1-4e0a-8bfb-34c14ef6bb75",
        "specimen": "8e896530-8186-496d-b937-13e152a11a60",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1134,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su005_su005_pre_PRJNA509910-su005_pre-CELL": {
        "akc_id": "694cafe1-3f43-421d-a75f-422736d42804",
        "specimen": "8e896530-8186-496d-b937-13e152a11a60",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su005_su005_pre_PRJNA509910-su005_pre-CELL": {
        "akc_id": "ccffeef1-03d0-411a-9374-2999f6ed52f4",
        "specimen": "8e896530-8186-496d-b937-13e152a11a60",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su005_su005_pre_PRJNA509910-su005_pre-TRB-CLONE": {
        "akc_id": "b40ed523-31e3-473d-a810-6691e2681e2e",
        "specimen": "8e896530-8186-496d-b937-13e152a11a60",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 839,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su005_su005_pre_PRJNA509910-su005_pre-TRB-CLONE": {
        "akc_id": "37ab1203-8bdf-4eae-bad8-086814559259",
        "specimen": "8e896530-8186-496d-b937-13e152a11a60",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su005_su005_pre_PRJNA509910-su005_pre-TRB-CLONE": {
        "akc_id": "e9fa67a2-54dc-4987-b2eb-6137c14b512e",
        "specimen": "8e896530-8186-496d-b937-13e152a11a60",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su006_su006_post_PRJNA509910-su006_post-TRA": {
        "akc_id": "a1f43daa-5f48-47a6-8829-4bef014c81e7",
        "specimen": "03ded81a-a5a0-4eac-9d6d-0f76e98e8322",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1784,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su006_su006_post_PRJNA509910-su006_post-TRA": {
        "akc_id": "04bd7c5d-e2a3-4d40-9799-13d59d6c27c9",
        "specimen": "03ded81a-a5a0-4eac-9d6d-0f76e98e8322",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su006_su006_post_PRJNA509910-su006_post-TRA": {
        "akc_id": "dfd4bfee-fb2e-40f6-9941-ecd35884f673",
        "specimen": "03ded81a-a5a0-4eac-9d6d-0f76e98e8322",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su006_su006_post_PRJNA509910-su006_post-TRB": {
        "akc_id": "85020477-699f-4688-80dd-39e8fab00715",
        "specimen": "03ded81a-a5a0-4eac-9d6d-0f76e98e8322",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1784,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su006_su006_post_PRJNA509910-su006_post-TRB": {
        "akc_id": "78778582-4d7a-485f-a445-021f340473a7",
        "specimen": "03ded81a-a5a0-4eac-9d6d-0f76e98e8322",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su006_su006_post_PRJNA509910-su006_post-TRB": {
        "akc_id": "44e02ce4-b3eb-4e87-b776-5f73c40579f4",
        "specimen": "03ded81a-a5a0-4eac-9d6d-0f76e98e8322",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su006_su006_post_PRJNA509910-su006_post-CELL": {
        "akc_id": "fc2f5e78-e6ae-414f-a273-4322af9d2b3d",
        "specimen": "03ded81a-a5a0-4eac-9d6d-0f76e98e8322",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2034,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su006_su006_post_PRJNA509910-su006_post-CELL": {
        "akc_id": "08b83849-c90a-422d-ab4d-c2f88a8d0245",
        "specimen": "03ded81a-a5a0-4eac-9d6d-0f76e98e8322",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su006_su006_post_PRJNA509910-su006_post-CELL": {
        "akc_id": "64460e02-9ea6-4e26-96c0-75726f6c5917",
        "specimen": "03ded81a-a5a0-4eac-9d6d-0f76e98e8322",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su006_su006_post_PRJNA509910-su006_post-TRB-CLONE": {
        "akc_id": "bad7d589-d3d8-45d2-bff9-80b62c13337d",
        "specimen": "03ded81a-a5a0-4eac-9d6d-0f76e98e8322",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1784,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su006_su006_post_PRJNA509910-su006_post-TRB-CLONE": {
        "akc_id": "995e5e31-4fa6-4c91-9531-6aac9cf01b6c",
        "specimen": "03ded81a-a5a0-4eac-9d6d-0f76e98e8322",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su006_su006_post_PRJNA509910-su006_post-TRB-CLONE": {
        "akc_id": "bfd4c94d-f28a-4611-9a9c-856dca3963fb",
        "specimen": "03ded81a-a5a0-4eac-9d6d-0f76e98e8322",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su006_su006_pre_PRJNA509910-su006_pre-TRA": {
        "akc_id": "41bf9a59-6829-479e-8a42-ec2d8d104e5b",
        "specimen": "97273758-d2f8-4341-a421-674e8ec8cfc7",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2220,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su006_su006_pre_PRJNA509910-su006_pre-TRA": {
        "akc_id": "6c25b5bd-39a1-4459-9e35-8acc45bd9462",
        "specimen": "97273758-d2f8-4341-a421-674e8ec8cfc7",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su006_su006_pre_PRJNA509910-su006_pre-TRA": {
        "akc_id": "fc50c064-3925-4cc0-9a09-c298c09b2e5f",
        "specimen": "97273758-d2f8-4341-a421-674e8ec8cfc7",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su006_su006_pre_PRJNA509910-su006_pre-TRB": {
        "akc_id": "1a157c1a-1251-4301-834f-61d0a5e0f6fa",
        "specimen": "97273758-d2f8-4341-a421-674e8ec8cfc7",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2220,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su006_su006_pre_PRJNA509910-su006_pre-TRB": {
        "akc_id": "78b13456-133a-4b26-84f4-d78fd5676795",
        "specimen": "97273758-d2f8-4341-a421-674e8ec8cfc7",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su006_su006_pre_PRJNA509910-su006_pre-TRB": {
        "akc_id": "1340c927-043c-4e4c-a759-5ce79fe2f715",
        "specimen": "97273758-d2f8-4341-a421-674e8ec8cfc7",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su006_su006_pre_PRJNA509910-su006_pre-CELL": {
        "akc_id": "a9826d3d-165d-4c3b-8862-c37fb7a3bf71",
        "specimen": "97273758-d2f8-4341-a421-674e8ec8cfc7",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2281,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su006_su006_pre_PRJNA509910-su006_pre-CELL": {
        "akc_id": "64bd426d-14b5-4c7b-9e02-81c4bb603867",
        "specimen": "97273758-d2f8-4341-a421-674e8ec8cfc7",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su006_su006_pre_PRJNA509910-su006_pre-CELL": {
        "akc_id": "88c94cd5-3d7e-4e8a-999d-ba9e956c722c",
        "specimen": "97273758-d2f8-4341-a421-674e8ec8cfc7",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su006_su006_pre_PRJNA509910-su006_pre-TRB-CLONE": {
        "akc_id": "82842a8f-754c-4e91-88e4-dcd19f1f26b0",
        "specimen": "97273758-d2f8-4341-a421-674e8ec8cfc7",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2220,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su006_su006_pre_PRJNA509910-su006_pre-TRB-CLONE": {
        "akc_id": "50005e61-54dd-4cbe-a758-8d6070adb9f5",
        "specimen": "97273758-d2f8-4341-a421-674e8ec8cfc7",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su006_su006_pre_PRJNA509910-su006_pre-TRB-CLONE": {
        "akc_id": "8c4076ff-d665-4d33-8db1-8c466c601fd4",
        "specimen": "97273758-d2f8-4341-a421-674e8ec8cfc7",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su007_su007_post_PRJNA509910-su007_post-TRA": {
        "akc_id": "84928c72-736c-4b21-9434-11bbb9688266",
        "specimen": "c4772edb-4657-41ab-8686-a8c63f48181d",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 126,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su007_su007_post_PRJNA509910-su007_post-TRA": {
        "akc_id": "50039d97-bed7-4d9f-b819-a119752c3342",
        "specimen": "c4772edb-4657-41ab-8686-a8c63f48181d",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su007_su007_post_PRJNA509910-su007_post-TRA": {
        "akc_id": "6f9ac7df-789d-4378-938a-6cb046af7559",
        "specimen": "c4772edb-4657-41ab-8686-a8c63f48181d",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su007_su007_post_PRJNA509910-su007_post-TRB": {
        "akc_id": "9fda0a37-2329-4720-bcbf-e60a79a22d17",
        "specimen": "c4772edb-4657-41ab-8686-a8c63f48181d",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 126,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su007_su007_post_PRJNA509910-su007_post-TRB": {
        "akc_id": "a30cc70d-cd24-4292-b987-1d23c4867c4a",
        "specimen": "c4772edb-4657-41ab-8686-a8c63f48181d",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su007_su007_post_PRJNA509910-su007_post-TRB": {
        "akc_id": "00f8984f-65c8-4172-9a22-10c51b0ece27",
        "specimen": "c4772edb-4657-41ab-8686-a8c63f48181d",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su007_su007_post_PRJNA509910-su007_post-CELL": {
        "akc_id": "7ef58a46-8c20-4b4d-8dd9-82864749b7fb",
        "specimen": "c4772edb-4657-41ab-8686-a8c63f48181d",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 282,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su007_su007_post_PRJNA509910-su007_post-CELL": {
        "akc_id": "29ef027b-8631-4d16-a976-a50356dfd0a0",
        "specimen": "c4772edb-4657-41ab-8686-a8c63f48181d",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su007_su007_post_PRJNA509910-su007_post-CELL": {
        "akc_id": "cae8cadb-fcc1-4b42-8dd0-c092500d2ac4",
        "specimen": "c4772edb-4657-41ab-8686-a8c63f48181d",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su007_su007_post_PRJNA509910-su007_post-TRB-CLONE": {
        "akc_id": "fd24f013-34d0-44e0-917b-7179f71edcfc",
        "specimen": "c4772edb-4657-41ab-8686-a8c63f48181d",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 126,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su007_su007_post_PRJNA509910-su007_post-TRB-CLONE": {
        "akc_id": "980fba8c-16bb-4153-b79e-5ce57f2eb994",
        "specimen": "c4772edb-4657-41ab-8686-a8c63f48181d",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su007_su007_post_PRJNA509910-su007_post-TRB-CLONE": {
        "akc_id": "527f26ac-3cda-418c-8b7b-ed9ee8e276a2",
        "specimen": "c4772edb-4657-41ab-8686-a8c63f48181d",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su007_su007_pre_PRJNA509910-su007_pre-TRA": {
        "akc_id": "b8a5a5fb-aaed-401a-8d2f-f91525c6cfdd",
        "specimen": "713165ec-b871-45a2-bf4e-8a94a188b4b5",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1115,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su007_su007_pre_PRJNA509910-su007_pre-TRA": {
        "akc_id": "31885e89-06d4-4f87-a8da-7626384e47d3",
        "specimen": "713165ec-b871-45a2-bf4e-8a94a188b4b5",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su007_su007_pre_PRJNA509910-su007_pre-TRA": {
        "akc_id": "8a29e172-38d4-4ece-96a5-179db894aa3b",
        "specimen": "713165ec-b871-45a2-bf4e-8a94a188b4b5",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su007_su007_pre_PRJNA509910-su007_pre-TRB": {
        "akc_id": "5779e1cb-a554-4d49-a58d-7effa5addbb7",
        "specimen": "713165ec-b871-45a2-bf4e-8a94a188b4b5",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1115,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su007_su007_pre_PRJNA509910-su007_pre-TRB": {
        "akc_id": "c46f596d-d8e7-4e11-9bb0-a8d03e5d0c76",
        "specimen": "713165ec-b871-45a2-bf4e-8a94a188b4b5",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su007_su007_pre_PRJNA509910-su007_pre-TRB": {
        "akc_id": "4dada853-5cc6-454f-9758-fef15e863349",
        "specimen": "713165ec-b871-45a2-bf4e-8a94a188b4b5",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su007_su007_pre_PRJNA509910-su007_pre-CELL": {
        "akc_id": "690e2231-8106-4a37-8dc1-409f2c2a91cc",
        "specimen": "713165ec-b871-45a2-bf4e-8a94a188b4b5",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1532,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su007_su007_pre_PRJNA509910-su007_pre-CELL": {
        "akc_id": "24422575-bccd-4a68-8b4d-193ebebe71dd",
        "specimen": "713165ec-b871-45a2-bf4e-8a94a188b4b5",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su007_su007_pre_PRJNA509910-su007_pre-CELL": {
        "akc_id": "c9e93b77-47cf-4d73-b28d-307cb540fc97",
        "specimen": "713165ec-b871-45a2-bf4e-8a94a188b4b5",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su007_su007_pre_PRJNA509910-su007_pre-TRB-CLONE": {
        "akc_id": "ffa36208-cd0f-4367-8812-583b8e78b867",
        "specimen": "713165ec-b871-45a2-bf4e-8a94a188b4b5",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1115,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su007_su007_pre_PRJNA509910-su007_pre-TRB-CLONE": {
        "akc_id": "dd2806ca-d561-45f2-9ab7-c8f62115b6a8",
        "specimen": "713165ec-b871-45a2-bf4e-8a94a188b4b5",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su007_su007_pre_PRJNA509910-su007_pre-TRB-CLONE": {
        "akc_id": "209b6dcd-33f5-4bc7-9180-88261b6cd4df",
        "specimen": "713165ec-b871-45a2-bf4e-8a94a188b4b5",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su008_su008_post_PRJNA509910-su008_post-TRA": {
        "akc_id": "528ec56b-e18f-4cf2-8361-665e21f2a51d",
        "specimen": "ce5f0e9d-168e-4e92-bed1-130ac7c567cd",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3191,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su008_su008_post_PRJNA509910-su008_post-TRA": {
        "akc_id": "3fae75c2-5064-409a-8633-ecd0c46f7e2f",
        "specimen": "ce5f0e9d-168e-4e92-bed1-130ac7c567cd",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su008_su008_post_PRJNA509910-su008_post-TRA": {
        "akc_id": "317ac885-5bff-4f54-b165-021a2d7d7d89",
        "specimen": "ce5f0e9d-168e-4e92-bed1-130ac7c567cd",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su008_su008_post_PRJNA509910-su008_post-TRB": {
        "akc_id": "0e142fbc-428c-4995-8401-81ff6af76023",
        "specimen": "ce5f0e9d-168e-4e92-bed1-130ac7c567cd",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3191,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su008_su008_post_PRJNA509910-su008_post-TRB": {
        "akc_id": "be30b2ad-682c-4ed4-8d9c-2382db7cf85b",
        "specimen": "ce5f0e9d-168e-4e92-bed1-130ac7c567cd",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su008_su008_post_PRJNA509910-su008_post-TRB": {
        "akc_id": "e29ef47a-5736-4e8e-8cdb-413521ad5a37",
        "specimen": "ce5f0e9d-168e-4e92-bed1-130ac7c567cd",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su008_su008_post_PRJNA509910-su008_post-CELL": {
        "akc_id": "c7bf48f7-5b07-4b82-b386-bc73020ea582",
        "specimen": "ce5f0e9d-168e-4e92-bed1-130ac7c567cd",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3999,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su008_su008_post_PRJNA509910-su008_post-CELL": {
        "akc_id": "d6b22039-ff64-423f-a1d6-bee69598595f",
        "specimen": "ce5f0e9d-168e-4e92-bed1-130ac7c567cd",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su008_su008_post_PRJNA509910-su008_post-CELL": {
        "akc_id": "fb30d150-6ce0-4712-b76d-4c7d3e19928d",
        "specimen": "ce5f0e9d-168e-4e92-bed1-130ac7c567cd",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su008_su008_post_PRJNA509910-su008_post-TRB-CLONE": {
        "akc_id": "d4384410-cfee-4a3d-836b-3473aa57d867",
        "specimen": "ce5f0e9d-168e-4e92-bed1-130ac7c567cd",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3191,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su008_su008_post_PRJNA509910-su008_post-TRB-CLONE": {
        "akc_id": "c9a7acf3-80c4-46a7-8cd6-75a540312010",
        "specimen": "ce5f0e9d-168e-4e92-bed1-130ac7c567cd",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su008_su008_post_PRJNA509910-su008_post-TRB-CLONE": {
        "akc_id": "f6f6606f-76b7-47e3-b37c-5632ce3f25c2",
        "specimen": "ce5f0e9d-168e-4e92-bed1-130ac7c567cd",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su008_su008_pre_PRJNA509910-su008_pre-TRA": {
        "akc_id": "fe87d1b9-eba9-428b-b29e-1f79d1823b48",
        "specimen": "91d127ff-e71a-48b5-b640-71d3d4fd841e",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1065,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su008_su008_pre_PRJNA509910-su008_pre-TRA": {
        "akc_id": "43dd7fd9-10d0-401f-a90e-62a2b1c3122e",
        "specimen": "91d127ff-e71a-48b5-b640-71d3d4fd841e",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su008_su008_pre_PRJNA509910-su008_pre-TRA": {
        "akc_id": "0e5c394f-f301-41fe-a9fc-2b194e1839f8",
        "specimen": "91d127ff-e71a-48b5-b640-71d3d4fd841e",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su008_su008_pre_PRJNA509910-su008_pre-TRB": {
        "akc_id": "9b6fb41e-c25a-4145-b247-e564770d24f2",
        "specimen": "91d127ff-e71a-48b5-b640-71d3d4fd841e",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1065,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su008_su008_pre_PRJNA509910-su008_pre-TRB": {
        "akc_id": "7981e9d7-a549-41f6-a47a-1334cfc71d4e",
        "specimen": "91d127ff-e71a-48b5-b640-71d3d4fd841e",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su008_su008_pre_PRJNA509910-su008_pre-TRB": {
        "akc_id": "603ad96c-08cd-43ab-a57e-62ea938a04f0",
        "specimen": "91d127ff-e71a-48b5-b640-71d3d4fd841e",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su008_su008_pre_PRJNA509910-su008_pre-CELL": {
        "akc_id": "4906a65d-de09-429a-9bbe-2b4431d35c28",
        "specimen": "91d127ff-e71a-48b5-b640-71d3d4fd841e",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1365,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su008_su008_pre_PRJNA509910-su008_pre-CELL": {
        "akc_id": "37d8e97d-65f7-4033-9fff-1a2c78f38cf6",
        "specimen": "91d127ff-e71a-48b5-b640-71d3d4fd841e",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su008_su008_pre_PRJNA509910-su008_pre-CELL": {
        "akc_id": "abeff807-9523-4a2a-b9c8-fbe47143f9c3",
        "specimen": "91d127ff-e71a-48b5-b640-71d3d4fd841e",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su008_su008_pre_PRJNA509910-su008_pre-TRB-CLONE": {
        "akc_id": "33c499d5-86fa-4286-a59c-9db551749645",
        "specimen": "91d127ff-e71a-48b5-b640-71d3d4fd841e",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1065,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su008_su008_pre_PRJNA509910-su008_pre-TRB-CLONE": {
        "akc_id": "06436828-ae00-4d6c-b388-a18691f12805",
        "specimen": "91d127ff-e71a-48b5-b640-71d3d4fd841e",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su008_su008_pre_PRJNA509910-su008_pre-TRB-CLONE": {
        "akc_id": "6be80d2c-1450-4a46-91ea-b6f546283d99",
        "specimen": "91d127ff-e71a-48b5-b640-71d3d4fd841e",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su009_su009_post_PRJNA509910-su009_post-TRA": {
        "akc_id": "1fc31af3-8f31-42df-80f5-8826ae5e1519",
        "specimen": "457d6780-148c-41be-ae42-80d074d9e2cc",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4487,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su009_su009_post_PRJNA509910-su009_post-TRA": {
        "akc_id": "254d4c2d-0c5d-4472-9f62-c32ed08648a6",
        "specimen": "457d6780-148c-41be-ae42-80d074d9e2cc",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su009_su009_post_PRJNA509910-su009_post-TRA": {
        "akc_id": "db4ab4d8-3762-463e-bfcc-b09aa05ad7a1",
        "specimen": "457d6780-148c-41be-ae42-80d074d9e2cc",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su009_su009_post_PRJNA509910-su009_post-TRB": {
        "akc_id": "19bf5049-5eff-4a74-988a-a9bf8305af47",
        "specimen": "457d6780-148c-41be-ae42-80d074d9e2cc",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4487,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su009_su009_post_PRJNA509910-su009_post-TRB": {
        "akc_id": "dc4348d7-5fe2-4044-be83-74196b4a73b1",
        "specimen": "457d6780-148c-41be-ae42-80d074d9e2cc",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su009_su009_post_PRJNA509910-su009_post-TRB": {
        "akc_id": "10c14988-9697-4a9f-b2f2-5a29122ff5ae",
        "specimen": "457d6780-148c-41be-ae42-80d074d9e2cc",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su009_su009_post_PRJNA509910-su009_post-CELL": {
        "akc_id": "3af0835c-c264-452e-adf7-65a80002ab26",
        "specimen": "457d6780-148c-41be-ae42-80d074d9e2cc",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 6081,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su009_su009_post_PRJNA509910-su009_post-CELL": {
        "akc_id": "569d139e-754f-4c50-9998-8553e6c10683",
        "specimen": "457d6780-148c-41be-ae42-80d074d9e2cc",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su009_su009_post_PRJNA509910-su009_post-CELL": {
        "akc_id": "9a8b9777-6030-49ad-96f5-77f2451f2e7b",
        "specimen": "457d6780-148c-41be-ae42-80d074d9e2cc",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su009_su009_post_PRJNA509910-su009_post-TRB-CLONE": {
        "akc_id": "43ed8634-e82a-4922-87b0-faedaf088ab3",
        "specimen": "457d6780-148c-41be-ae42-80d074d9e2cc",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4487,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su009_su009_post_PRJNA509910-su009_post-TRB-CLONE": {
        "akc_id": "b8728013-77e0-4988-ba8c-895533fd99d1",
        "specimen": "457d6780-148c-41be-ae42-80d074d9e2cc",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su009_su009_post_PRJNA509910-su009_post-TRB-CLONE": {
        "akc_id": "20622c17-65cc-46e4-95be-a9aa8ef83a72",
        "specimen": "457d6780-148c-41be-ae42-80d074d9e2cc",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su009_su009_pre_PRJNA509910-su009_pre-TRA": {
        "akc_id": "93b92a4b-1925-456e-b21e-db616f08cb9f",
        "specimen": "c96e4ef1-eada-4efa-b9a1-f18c0f3fbea9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3375,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su009_su009_pre_PRJNA509910-su009_pre-TRA": {
        "akc_id": "16a24978-699d-443e-a300-8472ca582da3",
        "specimen": "c96e4ef1-eada-4efa-b9a1-f18c0f3fbea9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su009_su009_pre_PRJNA509910-su009_pre-TRA": {
        "akc_id": "db587dd6-a49e-411b-ad12-47f36ce1e54f",
        "specimen": "c96e4ef1-eada-4efa-b9a1-f18c0f3fbea9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su009_su009_pre_PRJNA509910-su009_pre-TRB": {
        "akc_id": "242d8f47-69b7-4f51-b639-e305669db32c",
        "specimen": "c96e4ef1-eada-4efa-b9a1-f18c0f3fbea9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3375,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su009_su009_pre_PRJNA509910-su009_pre-TRB": {
        "akc_id": "d3361e14-3193-49fe-9274-464936063f57",
        "specimen": "c96e4ef1-eada-4efa-b9a1-f18c0f3fbea9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su009_su009_pre_PRJNA509910-su009_pre-TRB": {
        "akc_id": "57825f85-f63d-48ef-8294-6e23a999c890",
        "specimen": "c96e4ef1-eada-4efa-b9a1-f18c0f3fbea9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su009_su009_pre_PRJNA509910-su009_pre-CELL": {
        "akc_id": "8d675b2a-e8cf-4e75-9109-e96d20ecaf41",
        "specimen": "c96e4ef1-eada-4efa-b9a1-f18c0f3fbea9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 5342,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su009_su009_pre_PRJNA509910-su009_pre-CELL": {
        "akc_id": "935780ff-f0d7-49c9-a374-104791a172ca",
        "specimen": "c96e4ef1-eada-4efa-b9a1-f18c0f3fbea9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su009_su009_pre_PRJNA509910-su009_pre-CELL": {
        "akc_id": "d66fd488-9162-47b9-9ba2-ca58b47922a7",
        "specimen": "c96e4ef1-eada-4efa-b9a1-f18c0f3fbea9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su009_su009_pre_PRJNA509910-su009_pre-TRB-CLONE": {
        "akc_id": "d4eead27-7963-4308-a3d8-a78707e90903",
        "specimen": "c96e4ef1-eada-4efa-b9a1-f18c0f3fbea9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3375,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su009_su009_pre_PRJNA509910-su009_pre-TRB-CLONE": {
        "akc_id": "6f94d10d-ff63-4c99-9dc9-343778cdc61e",
        "specimen": "c96e4ef1-eada-4efa-b9a1-f18c0f3fbea9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su009_su009_pre_PRJNA509910-su009_pre-TRB-CLONE": {
        "akc_id": "f7bd009f-8411-445a-9e64-13c32cdf839d",
        "specimen": "c96e4ef1-eada-4efa-b9a1-f18c0f3fbea9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_post_BCC_PRJNA509910-su010_post_BCC-TRA": {
        "akc_id": "5498369c-48ef-4027-a0e0-b09b80263520",
        "specimen": "feaf45db-0897-4ec3-be06-c9c5339bf144",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 448,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_post_BCC_PRJNA509910-su010_post_BCC-TRA": {
        "akc_id": "edab51ed-128a-4491-9697-5800c4223916",
        "specimen": "feaf45db-0897-4ec3-be06-c9c5339bf144",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_post_BCC_PRJNA509910-su010_post_BCC-TRA": {
        "akc_id": "3979181b-78d7-464b-862c-1eb18b4b0612",
        "specimen": "feaf45db-0897-4ec3-be06-c9c5339bf144",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_post_BCC_PRJNA509910-su010_post_BCC-TRB": {
        "akc_id": "d7daafc3-5fa8-40e3-bf71-1c3ece1ed77b",
        "specimen": "feaf45db-0897-4ec3-be06-c9c5339bf144",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 448,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_post_BCC_PRJNA509910-su010_post_BCC-TRB": {
        "akc_id": "bdf53b30-ca55-4954-8d5a-72d10c3ecee6",
        "specimen": "feaf45db-0897-4ec3-be06-c9c5339bf144",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_post_BCC_PRJNA509910-su010_post_BCC-TRB": {
        "akc_id": "e8997fd8-2bae-4bba-bdea-0daab2027c70",
        "specimen": "feaf45db-0897-4ec3-be06-c9c5339bf144",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_post_BCC_PRJNA509910-su010_post_BCC-CELL": {
        "akc_id": "01139274-ad00-489d-b700-387c6f4b61d6",
        "specimen": "feaf45db-0897-4ec3-be06-c9c5339bf144",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 549,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_post_BCC_PRJNA509910-su010_post_BCC-CELL": {
        "akc_id": "484acfeb-6f07-473c-a96e-e63939535ab4",
        "specimen": "feaf45db-0897-4ec3-be06-c9c5339bf144",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_post_BCC_PRJNA509910-su010_post_BCC-CELL": {
        "akc_id": "ddfd4afb-b3fd-4a62-92cd-f786330a089e",
        "specimen": "feaf45db-0897-4ec3-be06-c9c5339bf144",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_post_BCC_PRJNA509910-su010_post_BCC-TRB-CLONE": {
        "akc_id": "dda05d18-edcc-4352-9a29-0a2956219d28",
        "specimen": "feaf45db-0897-4ec3-be06-c9c5339bf144",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 448,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_post_BCC_PRJNA509910-su010_post_BCC-TRB-CLONE": {
        "akc_id": "b32cac76-5501-4cc1-9921-d212f9f9552f",
        "specimen": "feaf45db-0897-4ec3-be06-c9c5339bf144",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_post_BCC_PRJNA509910-su010_post_BCC-TRB-CLONE": {
        "akc_id": "9d4b671f-d75d-40bd-8e2a-48166b001e89",
        "specimen": "feaf45db-0897-4ec3-be06-c9c5339bf144",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_post_SCC_PRJNA509910-su010_post_SCC-TRA": {
        "akc_id": "926769e0-397a-42e2-9ca8-57b63c66c68f",
        "specimen": "8fca3d1e-3e21-436b-a687-d87a4d5a1145",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 11425,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_post_SCC_PRJNA509910-su010_post_SCC-TRA": {
        "akc_id": "c2cba84c-d3cc-4593-bea4-325d20e2c7ca",
        "specimen": "8fca3d1e-3e21-436b-a687-d87a4d5a1145",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_post_SCC_PRJNA509910-su010_post_SCC-TRA": {
        "akc_id": "0dc004cc-949e-489d-a6db-0e096336155c",
        "specimen": "8fca3d1e-3e21-436b-a687-d87a4d5a1145",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_post_SCC_PRJNA509910-su010_post_SCC-TRB": {
        "akc_id": "5095412f-9805-4272-91f1-6cd6adf858fc",
        "specimen": "8fca3d1e-3e21-436b-a687-d87a4d5a1145",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 11425,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_post_SCC_PRJNA509910-su010_post_SCC-TRB": {
        "akc_id": "f625d302-f132-4071-b3da-c92b58773842",
        "specimen": "8fca3d1e-3e21-436b-a687-d87a4d5a1145",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_post_SCC_PRJNA509910-su010_post_SCC-TRB": {
        "akc_id": "0c1fb8a8-4b63-4945-926d-5515433ba85d",
        "specimen": "8fca3d1e-3e21-436b-a687-d87a4d5a1145",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_post_SCC_PRJNA509910-su010_post_SCC-CELL": {
        "akc_id": "380f1cf0-bbe5-4821-961a-ddbcac6625dd",
        "specimen": "8fca3d1e-3e21-436b-a687-d87a4d5a1145",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 11118,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_post_SCC_PRJNA509910-su010_post_SCC-CELL": {
        "akc_id": "d7816055-1610-4908-9d7f-ed33d2fedb47",
        "specimen": "8fca3d1e-3e21-436b-a687-d87a4d5a1145",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_post_SCC_PRJNA509910-su010_post_SCC-CELL": {
        "akc_id": "45aa6d44-f263-46fd-880a-3322715aa764",
        "specimen": "8fca3d1e-3e21-436b-a687-d87a4d5a1145",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_post_SCC_PRJNA509910-su010_post_SCC-TRB-CLONE": {
        "akc_id": "16059c3b-4e94-41a0-b137-b372dd80b1cb",
        "specimen": "8fca3d1e-3e21-436b-a687-d87a4d5a1145",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 11425,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_post_SCC_PRJNA509910-su010_post_SCC-TRB-CLONE": {
        "akc_id": "755c971d-b209-4322-bf37-e9d19f292464",
        "specimen": "8fca3d1e-3e21-436b-a687-d87a4d5a1145",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_post_SCC_PRJNA509910-su010_post_SCC-TRB-CLONE": {
        "akc_id": "11c06cf7-18d1-44e0-85c2-f2781504772a",
        "specimen": "8fca3d1e-3e21-436b-a687-d87a4d5a1145",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_post_SCC_CD39_PRJNA509910-su010_post_SCC_CD39-TRA": {
        "akc_id": "408fff4b-8d97-47df-9a51-f8a39ae59cc6",
        "specimen": "9a5c7eb0-45da-4eac-a7dd-ff119a11f7c5",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+CD8+CD39+",
        "single_cell": true,
        "cell_number": 5469,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_post_SCC_CD39_PRJNA509910-su010_post_SCC_CD39-TRA": {
        "akc_id": "f3102f76-ec1d-4d12-a930-77ce860d0aab",
        "specimen": "9a5c7eb0-45da-4eac-a7dd-ff119a11f7c5",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_post_SCC_CD39_PRJNA509910-su010_post_SCC_CD39-TRA": {
        "akc_id": "f5742a11-3a26-4e3c-a08f-8d4f8112ecf7",
        "specimen": "9a5c7eb0-45da-4eac-a7dd-ff119a11f7c5",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_post_SCC_CD39_PRJNA509910-su010_post_SCC_CD39-TRB": {
        "akc_id": "1426b08b-c5eb-430f-aa36-8c6b2190c1c9",
        "specimen": "9a5c7eb0-45da-4eac-a7dd-ff119a11f7c5",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+CD8+CD39+",
        "single_cell": true,
        "cell_number": 5469,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_post_SCC_CD39_PRJNA509910-su010_post_SCC_CD39-TRB": {
        "akc_id": "d585e8a9-2bd4-4974-be78-398b1bb0002c",
        "specimen": "9a5c7eb0-45da-4eac-a7dd-ff119a11f7c5",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_post_SCC_CD39_PRJNA509910-su010_post_SCC_CD39-TRB": {
        "akc_id": "357ba9e5-a034-48a6-91d8-13c8ee46343c",
        "specimen": "9a5c7eb0-45da-4eac-a7dd-ff119a11f7c5",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_post_SCC_CD39_PRJNA509910-su010_post_SCC_CD39-CELL": {
        "akc_id": "5910ef0a-f9c4-41c6-bea2-e67effb12917",
        "specimen": "9a5c7eb0-45da-4eac-a7dd-ff119a11f7c5",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+CD8+CD39+",
        "single_cell": true,
        "cell_number": 5392,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_post_SCC_CD39_PRJNA509910-su010_post_SCC_CD39-CELL": {
        "akc_id": "5f2cbe71-484d-4ac1-906f-9b08b5a89c6e",
        "specimen": "9a5c7eb0-45da-4eac-a7dd-ff119a11f7c5",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_post_SCC_CD39_PRJNA509910-su010_post_SCC_CD39-CELL": {
        "akc_id": "336deff8-6a9d-43a1-9f00-031947ce29a5",
        "specimen": "9a5c7eb0-45da-4eac-a7dd-ff119a11f7c5",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_post_SCC_CD39_PRJNA509910-su010_post_SCC_CD39-TRB-CLONE": {
        "akc_id": "9c71a377-0f3f-4ce5-a73e-016505bf8cfe",
        "specimen": "9a5c7eb0-45da-4eac-a7dd-ff119a11f7c5",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+CD8+CD39+",
        "single_cell": true,
        "cell_number": 5469,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_post_SCC_CD39_PRJNA509910-su010_post_SCC_CD39-TRB-CLONE": {
        "akc_id": "d2e5baf5-4796-4e13-a577-c940c61c0854",
        "specimen": "9a5c7eb0-45da-4eac-a7dd-ff119a11f7c5",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_post_SCC_CD39_PRJNA509910-su010_post_SCC_CD39-TRB-CLONE": {
        "akc_id": "a8e96abd-e8a3-4c04-89ac-4b3af5808808",
        "specimen": "9a5c7eb0-45da-4eac-a7dd-ff119a11f7c5",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_pre_BCC_PRJNA509910-su010_pre_BCC-TRA": {
        "akc_id": "b081b785-0a14-4579-a260-051cce1a3eaf",
        "specimen": "f3bd4408-e8a8-4d19-9ea9-22b823e69f8f",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 84,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_pre_BCC_PRJNA509910-su010_pre_BCC-TRA": {
        "akc_id": "de84ffc4-0850-41e0-b440-d847a415a07e",
        "specimen": "f3bd4408-e8a8-4d19-9ea9-22b823e69f8f",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_pre_BCC_PRJNA509910-su010_pre_BCC-TRA": {
        "akc_id": "460b1264-a87f-4a78-90a3-a16d5f7fae94",
        "specimen": "f3bd4408-e8a8-4d19-9ea9-22b823e69f8f",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_pre_BCC_PRJNA509910-su010_pre_BCC-TRB": {
        "akc_id": "0b051992-1c0b-4037-a45c-67779c321b8c",
        "specimen": "f3bd4408-e8a8-4d19-9ea9-22b823e69f8f",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 84,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_pre_BCC_PRJNA509910-su010_pre_BCC-TRB": {
        "akc_id": "cbe8411e-570e-46d7-b323-074a950d774c",
        "specimen": "f3bd4408-e8a8-4d19-9ea9-22b823e69f8f",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_pre_BCC_PRJNA509910-su010_pre_BCC-TRB": {
        "akc_id": "46b2df84-c942-4d2f-a207-753e9b3b7e86",
        "specimen": "f3bd4408-e8a8-4d19-9ea9-22b823e69f8f",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_pre_BCC_PRJNA509910-su010_pre_BCC-CELL": {
        "akc_id": "f3ed8b47-c8ef-4251-b63f-f5cb38881e01",
        "specimen": "f3bd4408-e8a8-4d19-9ea9-22b823e69f8f",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 136,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_pre_BCC_PRJNA509910-su010_pre_BCC-CELL": {
        "akc_id": "774b6169-a314-4939-b0ef-06a69aebe15a",
        "specimen": "f3bd4408-e8a8-4d19-9ea9-22b823e69f8f",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_pre_BCC_PRJNA509910-su010_pre_BCC-CELL": {
        "akc_id": "a1792049-7458-4ec0-bb98-ea5da70df43e",
        "specimen": "f3bd4408-e8a8-4d19-9ea9-22b823e69f8f",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_pre_BCC_PRJNA509910-su010_pre_BCC-TRB-CLONE": {
        "akc_id": "08cac81f-b802-4790-a64a-6bb2db00be72",
        "specimen": "f3bd4408-e8a8-4d19-9ea9-22b823e69f8f",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 84,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_pre_BCC_PRJNA509910-su010_pre_BCC-TRB-CLONE": {
        "akc_id": "12e1c68c-ec7c-45c3-8b20-52e37ed0a04d",
        "specimen": "f3bd4408-e8a8-4d19-9ea9-22b823e69f8f",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_pre_BCC_PRJNA509910-su010_pre_BCC-TRB-CLONE": {
        "akc_id": "737643f2-e0c0-44ea-b96f-f4164a5f2957",
        "specimen": "f3bd4408-e8a8-4d19-9ea9-22b823e69f8f",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_pre_SCC_rep1_PRJNA509910-su010_pre_SCC_rep1-TRA": {
        "akc_id": "fdcc23fa-9af9-4fcf-a2f9-ce23795809dd",
        "specimen": "c237d39b-5b5f-41e7-bcdc-234c1c3660b0",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1570,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_pre_SCC_rep1_PRJNA509910-su010_pre_SCC_rep1-TRA": {
        "akc_id": "aefd8c89-4b5c-4e81-b638-ee08a1433105",
        "specimen": "c237d39b-5b5f-41e7-bcdc-234c1c3660b0",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_pre_SCC_rep1_PRJNA509910-su010_pre_SCC_rep1-TRA": {
        "akc_id": "1a834e04-8d5d-40fc-b39d-e4cddb08c8bb",
        "specimen": "c237d39b-5b5f-41e7-bcdc-234c1c3660b0",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_pre_SCC_rep1_PRJNA509910-su010_pre_SCC_rep1-TRB": {
        "akc_id": "d2371667-ea67-4233-8791-56533040502e",
        "specimen": "c237d39b-5b5f-41e7-bcdc-234c1c3660b0",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1570,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_pre_SCC_rep1_PRJNA509910-su010_pre_SCC_rep1-TRB": {
        "akc_id": "139b3e1f-2b09-42e7-8f8c-6394f156d8aa",
        "specimen": "c237d39b-5b5f-41e7-bcdc-234c1c3660b0",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_pre_SCC_rep1_PRJNA509910-su010_pre_SCC_rep1-TRB": {
        "akc_id": "0bef2622-b454-4932-9a33-5c1ae73bf9fa",
        "specimen": "c237d39b-5b5f-41e7-bcdc-234c1c3660b0",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_pre_SCC_rep1_PRJNA509910-su010_pre_SCC_rep1-CELL": {
        "akc_id": "ac4d844d-ef72-4886-b0d9-829786cd262f",
        "specimen": "c237d39b-5b5f-41e7-bcdc-234c1c3660b0",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3149,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_pre_SCC_rep1_PRJNA509910-su010_pre_SCC_rep1-CELL": {
        "akc_id": "c293ec3d-2c4f-460e-ac21-537179315675",
        "specimen": "c237d39b-5b5f-41e7-bcdc-234c1c3660b0",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_pre_SCC_rep1_PRJNA509910-su010_pre_SCC_rep1-CELL": {
        "akc_id": "73e40bd7-e168-43eb-88eb-1a53aa019d2d",
        "specimen": "c237d39b-5b5f-41e7-bcdc-234c1c3660b0",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_pre_SCC_rep1_PRJNA509910-su010_pre_SCC_rep1-TRB-CLONE": {
        "akc_id": "fea205cb-feef-40d1-8bd0-6a436f02ebb9",
        "specimen": "c237d39b-5b5f-41e7-bcdc-234c1c3660b0",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1570,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_pre_SCC_rep1_PRJNA509910-su010_pre_SCC_rep1-TRB-CLONE": {
        "akc_id": "19c37218-e687-4e16-861a-80b7fdd1cfdc",
        "specimen": "c237d39b-5b5f-41e7-bcdc-234c1c3660b0",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_pre_SCC_rep1_PRJNA509910-su010_pre_SCC_rep1-TRB-CLONE": {
        "akc_id": "33b721fb-1831-4a01-a3a1-a79f61e2b218",
        "specimen": "c237d39b-5b5f-41e7-bcdc-234c1c3660b0",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_pre_SCC_rep2_PRJNA509910-su010_pre_SCC_rep2-TRA": {
        "akc_id": "3a2b2a51-9d8d-47b6-8d4e-8b4f35350edc",
        "specimen": "32da32b8-8270-4ae4-acf5-0ec5735f3f8d",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1384,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_pre_SCC_rep2_PRJNA509910-su010_pre_SCC_rep2-TRA": {
        "akc_id": "426b82ab-1df8-46f4-bfe8-a4a73283e227",
        "specimen": "32da32b8-8270-4ae4-acf5-0ec5735f3f8d",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_pre_SCC_rep2_PRJNA509910-su010_pre_SCC_rep2-TRA": {
        "akc_id": "047621d1-7a8b-4120-8257-74bfb735f5ea",
        "specimen": "32da32b8-8270-4ae4-acf5-0ec5735f3f8d",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_pre_SCC_rep2_PRJNA509910-su010_pre_SCC_rep2-TRB": {
        "akc_id": "981f8b63-51ee-4208-bbbc-798d8426abd5",
        "specimen": "32da32b8-8270-4ae4-acf5-0ec5735f3f8d",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1384,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_pre_SCC_rep2_PRJNA509910-su010_pre_SCC_rep2-TRB": {
        "akc_id": "b9692309-da5f-4a02-bb1d-0ac4f9c5eb2f",
        "specimen": "32da32b8-8270-4ae4-acf5-0ec5735f3f8d",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_pre_SCC_rep2_PRJNA509910-su010_pre_SCC_rep2-TRB": {
        "akc_id": "9c731ab9-1b0f-4f25-8fdf-4de0e4f75461",
        "specimen": "32da32b8-8270-4ae4-acf5-0ec5735f3f8d",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_pre_SCC_rep2_PRJNA509910-su010_pre_SCC_rep2-CELL": {
        "akc_id": "539d4047-cfeb-4b38-8ad5-a7e94fead5a9",
        "specimen": "32da32b8-8270-4ae4-acf5-0ec5735f3f8d",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2761,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_pre_SCC_rep2_PRJNA509910-su010_pre_SCC_rep2-CELL": {
        "akc_id": "fc330625-c5b7-4146-9895-d0e801f001d5",
        "specimen": "32da32b8-8270-4ae4-acf5-0ec5735f3f8d",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_pre_SCC_rep2_PRJNA509910-su010_pre_SCC_rep2-CELL": {
        "akc_id": "39d925f1-c5cd-4945-af75-30ac7b5764bb",
        "specimen": "32da32b8-8270-4ae4-acf5-0ec5735f3f8d",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su010_su010_pre_SCC_rep2_PRJNA509910-su010_pre_SCC_rep2-TRB-CLONE": {
        "akc_id": "741a163e-a7e8-43e9-a9ab-d54bc6447d65",
        "specimen": "32da32b8-8270-4ae4-acf5-0ec5735f3f8d",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1384,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su010_su010_pre_SCC_rep2_PRJNA509910-su010_pre_SCC_rep2-TRB-CLONE": {
        "akc_id": "f81030e1-77d0-479b-8d59-8a8e3c476def",
        "specimen": "32da32b8-8270-4ae4-acf5-0ec5735f3f8d",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su010_su010_pre_SCC_rep2_PRJNA509910-su010_pre_SCC_rep2-TRB-CLONE": {
        "akc_id": "995c938f-528a-4d11-95ab-3350de823817",
        "specimen": "32da32b8-8270-4ae4-acf5-0ec5735f3f8d",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su011_su011_post_PRJNA509910-su011_post-TRA": {
        "akc_id": "d61ccc40-f650-4567-8d72-04cbbc4bfb4c",
        "specimen": "5f8bc767-d12d-433c-85ba-780e8838f958",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4618,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su011_su011_post_PRJNA509910-su011_post-TRA": {
        "akc_id": "487fefd3-fc16-40f2-b85b-68d7b7ae5782",
        "specimen": "5f8bc767-d12d-433c-85ba-780e8838f958",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su011_su011_post_PRJNA509910-su011_post-TRA": {
        "akc_id": "6af1a586-39e3-40c3-a532-d86cc91d3ebd",
        "specimen": "5f8bc767-d12d-433c-85ba-780e8838f958",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su011_su011_post_PRJNA509910-su011_post-TRB": {
        "akc_id": "657489b0-249a-4f82-a847-7f8c892d39fd",
        "specimen": "5f8bc767-d12d-433c-85ba-780e8838f958",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4618,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su011_su011_post_PRJNA509910-su011_post-TRB": {
        "akc_id": "392218e9-77ab-4fcb-a243-cebdc00ff2f4",
        "specimen": "5f8bc767-d12d-433c-85ba-780e8838f958",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su011_su011_post_PRJNA509910-su011_post-TRB": {
        "akc_id": "fdd51544-4a59-44c3-95dc-f0fbb990fe94",
        "specimen": "5f8bc767-d12d-433c-85ba-780e8838f958",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su011_su011_post_PRJNA509910-su011_post-CELL": {
        "akc_id": "15547730-9f2f-419c-b480-31fc07393267",
        "specimen": "5f8bc767-d12d-433c-85ba-780e8838f958",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 6564,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su011_su011_post_PRJNA509910-su011_post-CELL": {
        "akc_id": "d430f9f0-4f2e-4a96-89ef-e2f87b9815e8",
        "specimen": "5f8bc767-d12d-433c-85ba-780e8838f958",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su011_su011_post_PRJNA509910-su011_post-CELL": {
        "akc_id": "1851da7e-9142-465e-918e-7f1cfeed75f9",
        "specimen": "5f8bc767-d12d-433c-85ba-780e8838f958",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su011_su011_post_PRJNA509910-su011_post-TRB-CLONE": {
        "akc_id": "c53da668-22cd-471c-bf0e-08b8a371bdf4",
        "specimen": "5f8bc767-d12d-433c-85ba-780e8838f958",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4618,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su011_su011_post_PRJNA509910-su011_post-TRB-CLONE": {
        "akc_id": "70be2d20-b3de-409c-a6b3-6de53bd663ba",
        "specimen": "5f8bc767-d12d-433c-85ba-780e8838f958",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su011_su011_post_PRJNA509910-su011_post-TRB-CLONE": {
        "akc_id": "6777c4ad-0b96-4025-9717-7c4da72b6d44",
        "specimen": "5f8bc767-d12d-433c-85ba-780e8838f958",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su011_su011_pre_rep1_PRJNA509910-su011_pre_rep1-TRA": {
        "akc_id": "b0211571-ec42-4b72-b268-71a85bae6568",
        "specimen": "34187e77-b08b-4162-8e28-4bda70b1aaeb",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1047,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su011_su011_pre_rep1_PRJNA509910-su011_pre_rep1-TRA": {
        "akc_id": "9734eba4-a514-4c73-a298-8634dd948cae",
        "specimen": "34187e77-b08b-4162-8e28-4bda70b1aaeb",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su011_su011_pre_rep1_PRJNA509910-su011_pre_rep1-TRA": {
        "akc_id": "0fc0a404-83c4-4c64-bc6e-e7978abce1f7",
        "specimen": "34187e77-b08b-4162-8e28-4bda70b1aaeb",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su011_su011_pre_rep1_PRJNA509910-su011_pre_rep1-TRB": {
        "akc_id": "e68a1b91-7996-4e47-bbf9-25003ea1eccf",
        "specimen": "34187e77-b08b-4162-8e28-4bda70b1aaeb",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1047,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su011_su011_pre_rep1_PRJNA509910-su011_pre_rep1-TRB": {
        "akc_id": "3aa57260-8be8-4d1a-b149-c83e5057fc34",
        "specimen": "34187e77-b08b-4162-8e28-4bda70b1aaeb",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su011_su011_pre_rep1_PRJNA509910-su011_pre_rep1-TRB": {
        "akc_id": "fde56e31-065a-4fd9-8384-f8b3c9c11f25",
        "specimen": "34187e77-b08b-4162-8e28-4bda70b1aaeb",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su011_su011_pre_rep1_PRJNA509910-su011_pre_rep1-CELL": {
        "akc_id": "09487562-a013-44ff-8da9-4adf42082086",
        "specimen": "34187e77-b08b-4162-8e28-4bda70b1aaeb",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1768,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su011_su011_pre_rep1_PRJNA509910-su011_pre_rep1-CELL": {
        "akc_id": "61d407c4-3d70-465b-a375-77b1971a671e",
        "specimen": "34187e77-b08b-4162-8e28-4bda70b1aaeb",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su011_su011_pre_rep1_PRJNA509910-su011_pre_rep1-CELL": {
        "akc_id": "5942affe-b974-4556-962c-5db72441a887",
        "specimen": "34187e77-b08b-4162-8e28-4bda70b1aaeb",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su011_su011_pre_rep1_PRJNA509910-su011_pre_rep1-TRB-CLONE": {
        "akc_id": "e261f26b-f416-4944-8b8d-03dfa0bd8db1",
        "specimen": "34187e77-b08b-4162-8e28-4bda70b1aaeb",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1047,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su011_su011_pre_rep1_PRJNA509910-su011_pre_rep1-TRB-CLONE": {
        "akc_id": "ce3d309e-48bc-4989-b941-9cf3edc50fe6",
        "specimen": "34187e77-b08b-4162-8e28-4bda70b1aaeb",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su011_su011_pre_rep1_PRJNA509910-su011_pre_rep1-TRB-CLONE": {
        "akc_id": "57cd13df-fa99-4aa9-a8b4-d7475e8cc258",
        "specimen": "34187e77-b08b-4162-8e28-4bda70b1aaeb",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su011_su011_pre_rep2_PRJNA509910-su011_pre_rep2-TRA": {
        "akc_id": "6d7259ee-d9a2-4790-84df-1d73c74b7193",
        "specimen": "c5e742de-5ec5-4c01-912e-f75e5e0efdf1",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1840,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su011_su011_pre_rep2_PRJNA509910-su011_pre_rep2-TRA": {
        "akc_id": "33abf081-3ee7-433a-9991-fc3a6912c073",
        "specimen": "c5e742de-5ec5-4c01-912e-f75e5e0efdf1",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su011_su011_pre_rep2_PRJNA509910-su011_pre_rep2-TRA": {
        "akc_id": "53c00ba9-03d4-4f7e-8308-2247d0fed33c",
        "specimen": "c5e742de-5ec5-4c01-912e-f75e5e0efdf1",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su011_su011_pre_rep2_PRJNA509910-su011_pre_rep2-TRB": {
        "akc_id": "5289fa2e-76f2-48ea-8eb5-23ed47d4505e",
        "specimen": "c5e742de-5ec5-4c01-912e-f75e5e0efdf1",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1840,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su011_su011_pre_rep2_PRJNA509910-su011_pre_rep2-TRB": {
        "akc_id": "226d4c87-c54a-4b25-92de-3b13c15d9490",
        "specimen": "c5e742de-5ec5-4c01-912e-f75e5e0efdf1",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su011_su011_pre_rep2_PRJNA509910-su011_pre_rep2-TRB": {
        "akc_id": "89cde57f-edb0-4d0b-9de8-5f687fd22353",
        "specimen": "c5e742de-5ec5-4c01-912e-f75e5e0efdf1",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su011_su011_pre_rep2_PRJNA509910-su011_pre_rep2-CELL": {
        "akc_id": "43c735cc-415e-41e7-bace-02d06031511e",
        "specimen": "c5e742de-5ec5-4c01-912e-f75e5e0efdf1",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2883,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su011_su011_pre_rep2_PRJNA509910-su011_pre_rep2-CELL": {
        "akc_id": "15bdc16e-a4e7-46df-b8d7-701a4606f0b1",
        "specimen": "c5e742de-5ec5-4c01-912e-f75e5e0efdf1",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su011_su011_pre_rep2_PRJNA509910-su011_pre_rep2-CELL": {
        "akc_id": "e68c4f06-0f98-4dc9-93de-00bc7be64d4c",
        "specimen": "c5e742de-5ec5-4c01-912e-f75e5e0efdf1",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su011_su011_pre_rep2_PRJNA509910-su011_pre_rep2-TRB-CLONE": {
        "akc_id": "aeaa3e53-0a15-4c8f-b3de-691e372815b5",
        "specimen": "c5e742de-5ec5-4c01-912e-f75e5e0efdf1",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1840,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su011_su011_pre_rep2_PRJNA509910-su011_pre_rep2-TRB-CLONE": {
        "akc_id": "b40831e0-213d-49be-8016-cbd91c144382",
        "specimen": "c5e742de-5ec5-4c01-912e-f75e5e0efdf1",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su011_su011_pre_rep2_PRJNA509910-su011_pre_rep2-TRB-CLONE": {
        "akc_id": "a24af59e-012b-4157-a7cd-af84066f6658",
        "specimen": "c5e742de-5ec5-4c01-912e-f75e5e0efdf1",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su012_su012_post_PRJNA509910-su012_post-TRA": {
        "akc_id": "4bac1c00-9792-45e7-941f-7b9b7c429e8e",
        "specimen": "a138fb4b-b5c7-4f32-bbb4-a085eafe0576",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 639,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su012_su012_post_PRJNA509910-su012_post-TRA": {
        "akc_id": "af4380e4-9ef4-4621-9043-059b26870df4",
        "specimen": "a138fb4b-b5c7-4f32-bbb4-a085eafe0576",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su012_su012_post_PRJNA509910-su012_post-TRA": {
        "akc_id": "9b5d7bea-88d6-48ab-9e78-319e5dc91b5f",
        "specimen": "a138fb4b-b5c7-4f32-bbb4-a085eafe0576",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su012_su012_post_PRJNA509910-su012_post-TRB": {
        "akc_id": "683b97d7-499c-4c27-9172-61904deea1ea",
        "specimen": "a138fb4b-b5c7-4f32-bbb4-a085eafe0576",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 639,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su012_su012_post_PRJNA509910-su012_post-TRB": {
        "akc_id": "9487659a-915f-48f9-b185-365f88465ae7",
        "specimen": "a138fb4b-b5c7-4f32-bbb4-a085eafe0576",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su012_su012_post_PRJNA509910-su012_post-TRB": {
        "akc_id": "eef8d7e2-f23b-4768-9f79-1b763a9e09ab",
        "specimen": "a138fb4b-b5c7-4f32-bbb4-a085eafe0576",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su012_su012_post_PRJNA509910-su012_post-CELL": {
        "akc_id": "d7317f35-4187-444c-8715-f35cdd3e874d",
        "specimen": "a138fb4b-b5c7-4f32-bbb4-a085eafe0576",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 809,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su012_su012_post_PRJNA509910-su012_post-CELL": {
        "akc_id": "d7d16bd7-b7b1-4ab1-b3fb-c042550f941f",
        "specimen": "a138fb4b-b5c7-4f32-bbb4-a085eafe0576",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su012_su012_post_PRJNA509910-su012_post-CELL": {
        "akc_id": "3dafa7eb-70c1-49af-9d77-3d8d79bfbb53",
        "specimen": "a138fb4b-b5c7-4f32-bbb4-a085eafe0576",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su012_su012_post_PRJNA509910-su012_post-TRB-CLONE": {
        "akc_id": "8dc85d5f-6659-46a4-abb2-531fac1414f3",
        "specimen": "a138fb4b-b5c7-4f32-bbb4-a085eafe0576",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 639,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su012_su012_post_PRJNA509910-su012_post-TRB-CLONE": {
        "akc_id": "5423f216-9343-428c-84c1-3cd500a8ceff",
        "specimen": "a138fb4b-b5c7-4f32-bbb4-a085eafe0576",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su012_su012_post_PRJNA509910-su012_post-TRB-CLONE": {
        "akc_id": "72a3090e-3a5a-4af8-afd7-cebc46b47926",
        "specimen": "a138fb4b-b5c7-4f32-bbb4-a085eafe0576",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su012_su012_pre_PRJNA509910-su012_pre-TRA": {
        "akc_id": "8bab530f-cbc6-41f7-97ab-20e83c27a5a7",
        "specimen": "0b47e42e-5035-427f-8d24-4d4a39da1af9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2327,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su012_su012_pre_PRJNA509910-su012_pre-TRA": {
        "akc_id": "4192bef5-b509-4e67-8631-14cd82504310",
        "specimen": "0b47e42e-5035-427f-8d24-4d4a39da1af9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su012_su012_pre_PRJNA509910-su012_pre-TRA": {
        "akc_id": "c29b1da7-78c6-4a36-9379-06791fe3e9f6",
        "specimen": "0b47e42e-5035-427f-8d24-4d4a39da1af9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su012_su012_pre_PRJNA509910-su012_pre-TRB": {
        "akc_id": "49ab1757-92ee-42a8-a9f2-1e187208886e",
        "specimen": "0b47e42e-5035-427f-8d24-4d4a39da1af9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2327,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su012_su012_pre_PRJNA509910-su012_pre-TRB": {
        "akc_id": "b9f6f52b-2652-4d77-88aa-30fc33b520be",
        "specimen": "0b47e42e-5035-427f-8d24-4d4a39da1af9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su012_su012_pre_PRJNA509910-su012_pre-TRB": {
        "akc_id": "7f62ac10-b1af-4fd4-81d8-161368620f4a",
        "specimen": "0b47e42e-5035-427f-8d24-4d4a39da1af9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su012_su012_pre_PRJNA509910-su012_pre-CELL": {
        "akc_id": "d09aeb2e-e3a9-4eca-b8f8-be52084e74a8",
        "specimen": "0b47e42e-5035-427f-8d24-4d4a39da1af9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2688,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su012_su012_pre_PRJNA509910-su012_pre-CELL": {
        "akc_id": "21822d99-d942-4771-9f75-3612936313f5",
        "specimen": "0b47e42e-5035-427f-8d24-4d4a39da1af9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su012_su012_pre_PRJNA509910-su012_pre-CELL": {
        "akc_id": "1d3fa314-fb07-4679-a5e5-17f9fc35c9a8",
        "specimen": "0b47e42e-5035-427f-8d24-4d4a39da1af9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su012_su012_pre_PRJNA509910-su012_pre-TRB-CLONE": {
        "akc_id": "e60bedde-411a-4c7c-94be-760df1399827",
        "specimen": "0b47e42e-5035-427f-8d24-4d4a39da1af9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2327,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su012_su012_pre_PRJNA509910-su012_pre-TRB-CLONE": {
        "akc_id": "3c55783e-077a-449e-95da-9adf71695c08",
        "specimen": "0b47e42e-5035-427f-8d24-4d4a39da1af9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su012_su012_pre_PRJNA509910-su012_pre-TRB-CLONE": {
        "akc_id": "c3a550ba-d81f-44fa-89e1-792d39352346",
        "specimen": "0b47e42e-5035-427f-8d24-4d4a39da1af9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su013_su013_post_PRJNA509910-su013_post-TRA": {
        "akc_id": "d5f40407-4987-4fb6-a5c9-88cb67d7564a",
        "specimen": "e3ed0e16-0481-421f-bfd0-4bfabe9df6d9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 57,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su013_su013_post_PRJNA509910-su013_post-TRA": {
        "akc_id": "76dbe16f-6fcd-4cd6-aca1-86954e7343a7",
        "specimen": "e3ed0e16-0481-421f-bfd0-4bfabe9df6d9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su013_su013_post_PRJNA509910-su013_post-TRA": {
        "akc_id": "0fe4a0b6-0a0c-4304-a1be-4367ab12062e",
        "specimen": "e3ed0e16-0481-421f-bfd0-4bfabe9df6d9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su013_su013_post_PRJNA509910-su013_post-TRB": {
        "akc_id": "db44c329-58fd-4889-9818-69635dc63e09",
        "specimen": "e3ed0e16-0481-421f-bfd0-4bfabe9df6d9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 57,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su013_su013_post_PRJNA509910-su013_post-TRB": {
        "akc_id": "ec0ad627-0bde-45fb-9baf-490d524804ad",
        "specimen": "e3ed0e16-0481-421f-bfd0-4bfabe9df6d9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su013_su013_post_PRJNA509910-su013_post-TRB": {
        "akc_id": "a7da5e6f-cb66-4484-84f4-aaf0a2fc736d",
        "specimen": "e3ed0e16-0481-421f-bfd0-4bfabe9df6d9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su013_su013_post_PRJNA509910-su013_post-CELL": {
        "akc_id": "2225cc3d-7179-4863-a8d7-80ecb6d265e0",
        "specimen": "e3ed0e16-0481-421f-bfd0-4bfabe9df6d9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 96,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su013_su013_post_PRJNA509910-su013_post-CELL": {
        "akc_id": "fda0b3b3-031c-45a3-826e-ab07f95c2634",
        "specimen": "e3ed0e16-0481-421f-bfd0-4bfabe9df6d9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su013_su013_post_PRJNA509910-su013_post-CELL": {
        "akc_id": "5bcba618-2b7f-42cb-a106-fa8b27322bb3",
        "specimen": "e3ed0e16-0481-421f-bfd0-4bfabe9df6d9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su013_su013_post_PRJNA509910-su013_post-TRB-CLONE": {
        "akc_id": "3d32f2d0-356d-4822-8025-4e5bc41d162c",
        "specimen": "e3ed0e16-0481-421f-bfd0-4bfabe9df6d9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 57,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su013_su013_post_PRJNA509910-su013_post-TRB-CLONE": {
        "akc_id": "2fd861b2-fe09-402a-9300-2de595ab594f",
        "specimen": "e3ed0e16-0481-421f-bfd0-4bfabe9df6d9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su013_su013_post_PRJNA509910-su013_post-TRB-CLONE": {
        "akc_id": "101164b7-1c90-4a50-9289-5cc72f68fc45",
        "specimen": "e3ed0e16-0481-421f-bfd0-4bfabe9df6d9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su013_su013_pre_PRJNA509910-su013_pre-TRA": {
        "akc_id": "45638445-54bc-40b9-973d-18d1a7845757",
        "specimen": "2e8792e2-2504-4656-83a5-97959b805206",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4483,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su013_su013_pre_PRJNA509910-su013_pre-TRA": {
        "akc_id": "0d21bdd4-0f37-4398-b7d3-69767383a669",
        "specimen": "2e8792e2-2504-4656-83a5-97959b805206",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su013_su013_pre_PRJNA509910-su013_pre-TRA": {
        "akc_id": "90388f56-0e5d-422a-9f0a-55334d151917",
        "specimen": "2e8792e2-2504-4656-83a5-97959b805206",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su013_su013_pre_PRJNA509910-su013_pre-TRB": {
        "akc_id": "3e52924e-e7b6-430d-996d-32cc773c6e88",
        "specimen": "2e8792e2-2504-4656-83a5-97959b805206",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4483,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su013_su013_pre_PRJNA509910-su013_pre-TRB": {
        "akc_id": "13c0d544-2181-4378-b953-a8548b7c3d7f",
        "specimen": "2e8792e2-2504-4656-83a5-97959b805206",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su013_su013_pre_PRJNA509910-su013_pre-TRB": {
        "akc_id": "5dab592c-f0b2-44fe-a43e-b2774b8867cf",
        "specimen": "2e8792e2-2504-4656-83a5-97959b805206",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su013_su013_pre_PRJNA509910-su013_pre-CELL": {
        "akc_id": "93218f55-cd25-4956-a1c5-b2378bbce514",
        "specimen": "2e8792e2-2504-4656-83a5-97959b805206",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 5268,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su013_su013_pre_PRJNA509910-su013_pre-CELL": {
        "akc_id": "212275d0-8c01-4c4b-a940-27ed0492167e",
        "specimen": "2e8792e2-2504-4656-83a5-97959b805206",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su013_su013_pre_PRJNA509910-su013_pre-CELL": {
        "akc_id": "7dccfbea-04ff-4cea-87cf-57868c57ea51",
        "specimen": "2e8792e2-2504-4656-83a5-97959b805206",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su013_su013_pre_PRJNA509910-su013_pre-TRB-CLONE": {
        "akc_id": "93f6e598-99d2-4b4d-bb89-b90a810be39b",
        "specimen": "2e8792e2-2504-4656-83a5-97959b805206",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4483,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su013_su013_pre_PRJNA509910-su013_pre-TRB-CLONE": {
        "akc_id": "5f7f7486-418d-4bfe-a7e8-a86285c9e781",
        "specimen": "2e8792e2-2504-4656-83a5-97959b805206",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su013_su013_pre_PRJNA509910-su013_pre-TRB-CLONE": {
        "akc_id": "74f3c5d0-5141-46d5-8258-ef0c9fced66d",
        "specimen": "2e8792e2-2504-4656-83a5-97959b805206",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su014_su014_post_PRJNA509910-su014_post-TRA": {
        "akc_id": "38e5a97f-3f4e-4a44-b0a3-d9cc0f913dec",
        "specimen": "934e884a-1c43-4e30-b12c-33682ab639b9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 556,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su014_su014_post_PRJNA509910-su014_post-TRA": {
        "akc_id": "6f684a0d-3c75-428c-a472-a5e67faf8a99",
        "specimen": "934e884a-1c43-4e30-b12c-33682ab639b9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su014_su014_post_PRJNA509910-su014_post-TRA": {
        "akc_id": "2f94d28e-c687-48b7-bfe5-dc717cb8d94e",
        "specimen": "934e884a-1c43-4e30-b12c-33682ab639b9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su014_su014_post_PRJNA509910-su014_post-TRB": {
        "akc_id": "26016a03-21be-43d0-8cd0-6933a8e3b976",
        "specimen": "934e884a-1c43-4e30-b12c-33682ab639b9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 556,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su014_su014_post_PRJNA509910-su014_post-TRB": {
        "akc_id": "d04b09bc-c934-4c55-a49c-58f4a1515a0c",
        "specimen": "934e884a-1c43-4e30-b12c-33682ab639b9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su014_su014_post_PRJNA509910-su014_post-TRB": {
        "akc_id": "eb977f0b-a727-4ff6-952f-2f7aed193767",
        "specimen": "934e884a-1c43-4e30-b12c-33682ab639b9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su014_su014_post_PRJNA509910-su014_post-CELL": {
        "akc_id": "62e8471d-2317-49b7-8d26-d2514d9eeae3",
        "specimen": "934e884a-1c43-4e30-b12c-33682ab639b9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 790,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su014_su014_post_PRJNA509910-su014_post-CELL": {
        "akc_id": "ff5b8316-e4e6-41d5-8a3e-44d087d8e13e",
        "specimen": "934e884a-1c43-4e30-b12c-33682ab639b9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su014_su014_post_PRJNA509910-su014_post-CELL": {
        "akc_id": "960790ef-01be-4e0b-8683-7c97c481e1dc",
        "specimen": "934e884a-1c43-4e30-b12c-33682ab639b9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su014_su014_post_PRJNA509910-su014_post-TRB-CLONE": {
        "akc_id": "5fe33883-8cd4-4ae9-9e0e-dcfdea590f1b",
        "specimen": "934e884a-1c43-4e30-b12c-33682ab639b9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 556,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su014_su014_post_PRJNA509910-su014_post-TRB-CLONE": {
        "akc_id": "ddff17d7-82aa-40b6-b469-4610fc713cf8",
        "specimen": "934e884a-1c43-4e30-b12c-33682ab639b9",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su014_su014_post_PRJNA509910-su014_post-TRB-CLONE": {
        "akc_id": "6105bec7-111d-4630-9564-bb24ee029ec5",
        "specimen": "934e884a-1c43-4e30-b12c-33682ab639b9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su014_su014_pre_PRJNA509910-su014_pre-TRA": {
        "akc_id": "cb88777d-4f78-4bef-a61b-40444a3d356a",
        "specimen": "41bb4eeb-dea3-406f-bb06-8f41283c5e3e",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2608,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su014_su014_pre_PRJNA509910-su014_pre-TRA": {
        "akc_id": "4989100f-7e18-4ab1-96ad-342f872863c7",
        "specimen": "41bb4eeb-dea3-406f-bb06-8f41283c5e3e",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su014_su014_pre_PRJNA509910-su014_pre-TRA": {
        "akc_id": "3e3f741c-b6dd-4495-b3a3-fde4dd460f84",
        "specimen": "41bb4eeb-dea3-406f-bb06-8f41283c5e3e",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su014_su014_pre_PRJNA509910-su014_pre-TRB": {
        "akc_id": "862ee472-9f8b-4400-97e0-a1a6961fe0be",
        "specimen": "41bb4eeb-dea3-406f-bb06-8f41283c5e3e",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2608,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su014_su014_pre_PRJNA509910-su014_pre-TRB": {
        "akc_id": "4892966d-1908-4fb6-bc01-61f8026787cb",
        "specimen": "41bb4eeb-dea3-406f-bb06-8f41283c5e3e",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su014_su014_pre_PRJNA509910-su014_pre-TRB": {
        "akc_id": "742a5e34-88fe-482e-a0e7-ae01a5bfc9fa",
        "specimen": "41bb4eeb-dea3-406f-bb06-8f41283c5e3e",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su014_su014_pre_PRJNA509910-su014_pre-CELL": {
        "akc_id": "02245dd7-ed33-476d-8fba-fffda8836d68",
        "specimen": "41bb4eeb-dea3-406f-bb06-8f41283c5e3e",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3049,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su014_su014_pre_PRJNA509910-su014_pre-CELL": {
        "akc_id": "c5900891-4555-4e58-b58c-02ddff1fd367",
        "specimen": "41bb4eeb-dea3-406f-bb06-8f41283c5e3e",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su014_su014_pre_PRJNA509910-su014_pre-CELL": {
        "akc_id": "beeeabbb-c12b-4f66-a36a-792ca5090469",
        "specimen": "41bb4eeb-dea3-406f-bb06-8f41283c5e3e",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      },
      "CellIsolationProcessing_su014_su014_pre_PRJNA509910-su014_pre-TRB-CLONE": {
        "akc_id": "1812405b-4c3e-4d15-b764-0128380e23a7",
        "specimen": "41bb4eeb-dea3-406f-bb06-8f41283c5e3e",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2608,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 μg/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3−) and malignant/stromal cells (CD45−CD3−). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+)."
      },
      "NucleicAcidProcessing_su014_su014_pre_PRJNA509910-su014_pre-TRB-CLONE": {
        "akc_id": "a4ed6852-cdbb-4598-9e6a-948bd177e7b5",
        "specimen": "41bb4eeb-dea3-406f-bb06-8f41283c5e3e",
        "template_class": "RNA"
      },
      "LibraryPreparationProcessing_su014_su014_pre_PRJNA509910-su014_pre-TRB-CLONE": {
        "akc_id": "b3e6ee8d-1a89-4fa9-8e25-1bec9a97943b",
        "specimen": "41bb4eeb-dea3-406f-bb06-8f41283c5e3e",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer’s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100–800 cells per μl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500–7,000 cells, resulting in estimated multiplet rates of 0.4–5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 °C for 45 s; 13–18 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Amplified cDNA was then used for both 5′ gene expression library construction and TCR enrichment. For gene expression library construction, 2.4–50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 °C for 45 s; 14–16 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 μl of amplified cDNA by PCR (primer sets 1 and 2: 98 °C for 45 s; 10 cycles of 98 °C for 20 s, 67 °C for 30 s, 72 °C for 1 min; 72 °C for 1 min). Following TCR enrichment, 5–50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 °C for 45 s; 9 cycles of 98 °C for 20 s, 54 °C for 30 s, 72 °C for 20 s; 72 °C for 1 min), and sizeselected with SPRIselect beads."
      }
    },
    "assays": {
      "ReceptorRepertoireSequencingAssay_su001_su001_post_PRJNA509910-su001_post-TRA": {
        "akc_id": "e831eb9e-2da9-4762-b3bb-27bd15bcb07a",
        "specimen": "3c45c787-a3e9-483d-9090-3c28b2a281ae",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su001_su001_post_PRJNA509910-su001_post-TRB": {
        "akc_id": "b8e140f2-728d-4ba1-a5a2-6ca703579b8c",
        "specimen": "3c45c787-a3e9-483d-9090-3c28b2a281ae",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su001_su001_post_PRJNA509910-su001_post-CELL": {
        "akc_id": "5eb8c566-0365-4258-a648-c8d46ff22985",
        "specimen": "3c45c787-a3e9-483d-9090-3c28b2a281ae",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su001_su001_post_PRJNA509910-su001_post-TRB-CLONE": {
        "akc_id": "e0a63684-5aae-4d0f-8fb7-bb039ce90c1b",
        "specimen": "3c45c787-a3e9-483d-9090-3c28b2a281ae",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su001_su001_pre1_PRJNA509910-su001_pre1-TRA": {
        "akc_id": "896decb0-3bd4-4a11-8b11-3574884e5c43",
        "specimen": "6097580c-4b2a-4be3-af29-dfe106b93ea5",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su001_su001_pre1_PRJNA509910-su001_pre1-TRB": {
        "akc_id": "c27f4826-16f5-4adf-9d95-b8f6900da3a0",
        "specimen": "6097580c-4b2a-4be3-af29-dfe106b93ea5",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su001_su001_pre1_PRJNA509910-su001_pre1-CELL": {
        "akc_id": "7bbef46a-4c2d-4c06-b76d-486c0e67dab4",
        "specimen": "6097580c-4b2a-4be3-af29-dfe106b93ea5",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su001_su001_pre1_PRJNA509910-su001_pre1-TRB-CLONE": {
        "akc_id": "3b1029f7-8f50-4d41-9908-3145ae627c35",
        "specimen": "6097580c-4b2a-4be3-af29-dfe106b93ea5",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su001_su001_pre2_PRJNA509910-su001_pre2-TRA": {
        "akc_id": "914110f3-4163-4249-aaeb-4213a51f953a",
        "specimen": "ff6a5174-a59d-4fcd-a8a1-25b12e3f4145",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su001_su001_pre2_PRJNA509910-su001_pre2-TRB": {
        "akc_id": "a58c8c85-8be6-43b3-9364-0638b629b2ff",
        "specimen": "ff6a5174-a59d-4fcd-a8a1-25b12e3f4145",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su001_su001_pre2_PRJNA509910-su001_pre2-CELL": {
        "akc_id": "f45d516c-8439-4c55-b2de-5da0302a90dc",
        "specimen": "ff6a5174-a59d-4fcd-a8a1-25b12e3f4145",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su001_su001_pre2_PRJNA509910-su001_pre2-TRB-CLONE": {
        "akc_id": "926ed3d2-0e3b-4306-8cef-85cc3955e663",
        "specimen": "ff6a5174-a59d-4fcd-a8a1-25b12e3f4145",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su002_su002_post_PRJNA509910-su002_post-TRA": {
        "akc_id": "4d82529a-d9e6-4f49-b168-df323d939413",
        "specimen": "eafe58d1-0f9d-4cb7-bafd-c6c1f6ec01f9",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su002_su002_post_PRJNA509910-su002_post-TRB": {
        "akc_id": "8142fe90-5262-4986-8878-c888dae77c50",
        "specimen": "eafe58d1-0f9d-4cb7-bafd-c6c1f6ec01f9",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su002_su002_post_PRJNA509910-su002_post-CELL": {
        "akc_id": "28e0735d-8850-411d-a9ad-ee334f119219",
        "specimen": "eafe58d1-0f9d-4cb7-bafd-c6c1f6ec01f9",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su002_su002_post_PRJNA509910-su002_post-TRB-CLONE": {
        "akc_id": "c925321a-8c76-4068-b512-557d371835af",
        "specimen": "eafe58d1-0f9d-4cb7-bafd-c6c1f6ec01f9",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su002_su002_pre_PRJNA509910-su002_pre-TRA": {
        "akc_id": "e3bf4747-3244-4344-ac25-56ff03ada04b",
        "specimen": "7c0cfdd4-06ad-4125-9427-2ca65edbca6e",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su002_su002_pre_PRJNA509910-su002_pre-TRB": {
        "akc_id": "865c4e6a-1f1a-4dec-b1c5-1c9a82c2da33",
        "specimen": "7c0cfdd4-06ad-4125-9427-2ca65edbca6e",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su002_su002_pre_PRJNA509910-su002_pre-CELL": {
        "akc_id": "4eb2cb82-adb6-4b10-8a92-96e497674778",
        "specimen": "7c0cfdd4-06ad-4125-9427-2ca65edbca6e",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su002_su002_pre_PRJNA509910-su002_pre-TRB-CLONE": {
        "akc_id": "9e7f394c-b499-491b-8cd2-d4b210462bdb",
        "specimen": "7c0cfdd4-06ad-4125-9427-2ca65edbca6e",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su003_su003_post_PRJNA509910-su003_post-TRA": {
        "akc_id": "389253bc-922b-49ca-93c8-4cd502b96eb7",
        "specimen": "b8bdbd34-0d0c-4a3d-a027-1b1e7fca9dac",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su003_su003_post_PRJNA509910-su003_post-TRB": {
        "akc_id": "e7cf0fbd-a8c6-478f-8d4d-ba1efb1008f5",
        "specimen": "b8bdbd34-0d0c-4a3d-a027-1b1e7fca9dac",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su003_su003_post_PRJNA509910-su003_post-CELL": {
        "akc_id": "52cd1311-abfa-4135-818d-ecd231d37ce4",
        "specimen": "b8bdbd34-0d0c-4a3d-a027-1b1e7fca9dac",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su003_su003_post_PRJNA509910-su003_post-TRB-CLONE": {
        "akc_id": "416be16f-9416-4654-aa8b-523ede3b8f97",
        "specimen": "b8bdbd34-0d0c-4a3d-a027-1b1e7fca9dac",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su003_su003_pre_PRJNA509910-su003_pre-TRA": {
        "akc_id": "2f32527b-ce4d-4578-8c8f-af8fd00d055f",
        "specimen": "4a62b2e5-7c83-47ad-8ef2-89e99f5c6376",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su003_su003_pre_PRJNA509910-su003_pre-TRB": {
        "akc_id": "a3d05024-9195-4cff-ad88-f995cbe419a1",
        "specimen": "4a62b2e5-7c83-47ad-8ef2-89e99f5c6376",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su003_su003_pre_PRJNA509910-su003_pre-CELL": {
        "akc_id": "e84bb766-899f-4540-b8a8-8bf33a8d5b04",
        "specimen": "4a62b2e5-7c83-47ad-8ef2-89e99f5c6376",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su003_su003_pre_PRJNA509910-su003_pre-TRB-CLONE": {
        "akc_id": "f57b3c47-dfb8-451b-b5bb-950e6c81b4ed",
        "specimen": "4a62b2e5-7c83-47ad-8ef2-89e99f5c6376",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su004_su004_post_PRJNA509910-su004_post-TRA": {
        "akc_id": "282ffe6a-efd9-45e6-9bde-40487d7fcf6a",
        "specimen": "bb0762c1-83d2-4719-a186-fdf56a48bf50",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su004_su004_post_PRJNA509910-su004_post-TRB": {
        "akc_id": "2bf16079-393d-41d6-b467-d55cb9ad7211",
        "specimen": "bb0762c1-83d2-4719-a186-fdf56a48bf50",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su004_su004_post_PRJNA509910-su004_post-CELL": {
        "akc_id": "17f88c83-f2cf-4450-aa48-0b9668b608a0",
        "specimen": "bb0762c1-83d2-4719-a186-fdf56a48bf50",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su004_su004_post_PRJNA509910-su004_post-TRB-CLONE": {
        "akc_id": "eb448c60-9ea2-4a13-b829-9d13783a2b1f",
        "specimen": "bb0762c1-83d2-4719-a186-fdf56a48bf50",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su004_su004_pre_PRJNA509910-su004_pre-TRA": {
        "akc_id": "4fcbe1d3-f3a2-4dbd-83b8-3c2180e73dd8",
        "specimen": "84eead8e-605f-4538-91dd-c08f3daf4443",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su004_su004_pre_PRJNA509910-su004_pre-TRB": {
        "akc_id": "d1dae7b7-171e-49b8-93a8-48cffdf32aa9",
        "specimen": "84eead8e-605f-4538-91dd-c08f3daf4443",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su004_su004_pre_PRJNA509910-su004_pre-CELL": {
        "akc_id": "70c78919-58de-493d-ad0e-802484f76ac4",
        "specimen": "84eead8e-605f-4538-91dd-c08f3daf4443",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su004_su004_pre_PRJNA509910-su004_pre-TRB-CLONE": {
        "akc_id": "04d07719-20f5-4329-81f3-96fa0b0b71c1",
        "specimen": "84eead8e-605f-4538-91dd-c08f3daf4443",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su005_su005_post_PRJNA509910-su005_post-TRA": {
        "akc_id": "ea6eb625-cd76-4967-bd6f-a3204087c80f",
        "specimen": "42e9e9bc-aa09-49bb-b681-97ccce06100e",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su005_su005_post_PRJNA509910-su005_post-TRB": {
        "akc_id": "bb9a6377-c63f-4abd-9e09-ca4a8a3111a7",
        "specimen": "42e9e9bc-aa09-49bb-b681-97ccce06100e",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su005_su005_post_PRJNA509910-su005_post-CELL": {
        "akc_id": "f71b2226-835d-481b-a6bd-84883a5f17b4",
        "specimen": "42e9e9bc-aa09-49bb-b681-97ccce06100e",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su005_su005_post_PRJNA509910-su005_post-TRB-CLONE": {
        "akc_id": "6075adfb-1bef-4ca1-b742-d83cc5ec4a6d",
        "specimen": "42e9e9bc-aa09-49bb-b681-97ccce06100e",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su005_su005_pre_PRJNA509910-su005_pre-TRA": {
        "akc_id": "d4e39d53-14aa-498b-aecd-19058cf711a0",
        "specimen": "8e896530-8186-496d-b937-13e152a11a60",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su005_su005_pre_PRJNA509910-su005_pre-TRB": {
        "akc_id": "39ed8c55-b185-4deb-a4fb-ceae743e3a6e",
        "specimen": "8e896530-8186-496d-b937-13e152a11a60",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su005_su005_pre_PRJNA509910-su005_pre-CELL": {
        "akc_id": "fc71d81b-1e32-4973-9b46-99eff10380d0",
        "specimen": "8e896530-8186-496d-b937-13e152a11a60",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su005_su005_pre_PRJNA509910-su005_pre-TRB-CLONE": {
        "akc_id": "e951e225-bc86-4aa1-b6dd-c2b71f046870",
        "specimen": "8e896530-8186-496d-b937-13e152a11a60",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su006_su006_post_PRJNA509910-su006_post-TRA": {
        "akc_id": "1f7f090b-b3ab-4d87-9612-79ad0db07eab",
        "specimen": "03ded81a-a5a0-4eac-9d6d-0f76e98e8322",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su006_su006_post_PRJNA509910-su006_post-TRB": {
        "akc_id": "40b87d10-4b32-4e03-ae63-15f35a1dc4a3",
        "specimen": "03ded81a-a5a0-4eac-9d6d-0f76e98e8322",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su006_su006_post_PRJNA509910-su006_post-CELL": {
        "akc_id": "851a594c-00c5-4bc8-be5e-1d85d7c8ace2",
        "specimen": "03ded81a-a5a0-4eac-9d6d-0f76e98e8322",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su006_su006_post_PRJNA509910-su006_post-TRB-CLONE": {
        "akc_id": "b17abd12-ef79-41f5-8182-1f9c87b42f77",
        "specimen": "03ded81a-a5a0-4eac-9d6d-0f76e98e8322",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su006_su006_pre_PRJNA509910-su006_pre-TRA": {
        "akc_id": "110b774e-491e-4847-b36e-8f6ecd7e0fe7",
        "specimen": "97273758-d2f8-4341-a421-674e8ec8cfc7",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su006_su006_pre_PRJNA509910-su006_pre-TRB": {
        "akc_id": "9ccc414f-e3c1-4678-a05b-7e6c963c183f",
        "specimen": "97273758-d2f8-4341-a421-674e8ec8cfc7",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su006_su006_pre_PRJNA509910-su006_pre-CELL": {
        "akc_id": "1a2c9593-e7a0-4dbf-a4bb-c8e13c98b547",
        "specimen": "97273758-d2f8-4341-a421-674e8ec8cfc7",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su006_su006_pre_PRJNA509910-su006_pre-TRB-CLONE": {
        "akc_id": "7472ad7d-42b2-4abd-beae-3869da54987a",
        "specimen": "97273758-d2f8-4341-a421-674e8ec8cfc7",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su007_su007_post_PRJNA509910-su007_post-TRA": {
        "akc_id": "29ea3f41-f12f-4d6d-aab3-82637f036a5e",
        "specimen": "c4772edb-4657-41ab-8686-a8c63f48181d",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su007_su007_post_PRJNA509910-su007_post-TRB": {
        "akc_id": "82489118-76a5-4b41-a619-5a4c206bb237",
        "specimen": "c4772edb-4657-41ab-8686-a8c63f48181d",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su007_su007_post_PRJNA509910-su007_post-CELL": {
        "akc_id": "920e930d-e046-4a44-8666-865a72926b04",
        "specimen": "c4772edb-4657-41ab-8686-a8c63f48181d",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su007_su007_post_PRJNA509910-su007_post-TRB-CLONE": {
        "akc_id": "6f0f1400-2718-4915-a7c3-3fa789824f99",
        "specimen": "c4772edb-4657-41ab-8686-a8c63f48181d",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su007_su007_pre_PRJNA509910-su007_pre-TRA": {
        "akc_id": "e7d04f77-6b06-46d2-b40b-53e4548003c4",
        "specimen": "713165ec-b871-45a2-bf4e-8a94a188b4b5",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su007_su007_pre_PRJNA509910-su007_pre-TRB": {
        "akc_id": "36832af5-eae1-4466-b1ee-9126513c1015",
        "specimen": "713165ec-b871-45a2-bf4e-8a94a188b4b5",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su007_su007_pre_PRJNA509910-su007_pre-CELL": {
        "akc_id": "30f62542-f9ab-401c-85d9-4111189689ae",
        "specimen": "713165ec-b871-45a2-bf4e-8a94a188b4b5",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su007_su007_pre_PRJNA509910-su007_pre-TRB-CLONE": {
        "akc_id": "da4214e9-ae1e-4ca7-aa8a-415c1ada45d1",
        "specimen": "713165ec-b871-45a2-bf4e-8a94a188b4b5",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su008_su008_post_PRJNA509910-su008_post-TRA": {
        "akc_id": "9d77c17a-332a-47c1-8807-23b6a4f70e7d",
        "specimen": "ce5f0e9d-168e-4e92-bed1-130ac7c567cd",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su008_su008_post_PRJNA509910-su008_post-TRB": {
        "akc_id": "d658f6b7-cd8b-45e3-b5ba-3b21baf4bcc5",
        "specimen": "ce5f0e9d-168e-4e92-bed1-130ac7c567cd",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su008_su008_post_PRJNA509910-su008_post-CELL": {
        "akc_id": "bedabad9-c9ef-4a0d-8edf-6a8fc1e6af90",
        "specimen": "ce5f0e9d-168e-4e92-bed1-130ac7c567cd",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su008_su008_post_PRJNA509910-su008_post-TRB-CLONE": {
        "akc_id": "27cc8fb2-c9b6-4346-b1db-44bae65e2809",
        "specimen": "ce5f0e9d-168e-4e92-bed1-130ac7c567cd",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su008_su008_pre_PRJNA509910-su008_pre-TRA": {
        "akc_id": "67188c81-3672-4bfb-9ea2-664a739bfe95",
        "specimen": "91d127ff-e71a-48b5-b640-71d3d4fd841e",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su008_su008_pre_PRJNA509910-su008_pre-TRB": {
        "akc_id": "ce72eac1-d49a-47bc-a93e-e5dc0d584116",
        "specimen": "91d127ff-e71a-48b5-b640-71d3d4fd841e",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su008_su008_pre_PRJNA509910-su008_pre-CELL": {
        "akc_id": "a4c2d121-4fc3-4125-9b5f-389cf359b935",
        "specimen": "91d127ff-e71a-48b5-b640-71d3d4fd841e",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su008_su008_pre_PRJNA509910-su008_pre-TRB-CLONE": {
        "akc_id": "d4594b89-1a59-4e3a-bd77-a351768cfbb8",
        "specimen": "91d127ff-e71a-48b5-b640-71d3d4fd841e",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su009_su009_post_PRJNA509910-su009_post-TRA": {
        "akc_id": "ece68b4c-742b-4193-8c6d-9aea4ddace6a",
        "specimen": "457d6780-148c-41be-ae42-80d074d9e2cc",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su009_su009_post_PRJNA509910-su009_post-TRB": {
        "akc_id": "550aa739-1c66-43e2-9618-7d8b0c21d3e3",
        "specimen": "457d6780-148c-41be-ae42-80d074d9e2cc",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su009_su009_post_PRJNA509910-su009_post-CELL": {
        "akc_id": "2b740a52-50c0-4b9e-a51e-e81533641bcc",
        "specimen": "457d6780-148c-41be-ae42-80d074d9e2cc",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su009_su009_post_PRJNA509910-su009_post-TRB-CLONE": {
        "akc_id": "d4530fa5-f498-4d60-911d-4889e3ac9896",
        "specimen": "457d6780-148c-41be-ae42-80d074d9e2cc",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su009_su009_pre_PRJNA509910-su009_pre-TRA": {
        "akc_id": "0c79444a-8e9b-4e0e-bbf1-65ec4291fcb0",
        "specimen": "c96e4ef1-eada-4efa-b9a1-f18c0f3fbea9",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su009_su009_pre_PRJNA509910-su009_pre-TRB": {
        "akc_id": "911f9112-711a-4153-be8b-dfa7fc932c0c",
        "specimen": "c96e4ef1-eada-4efa-b9a1-f18c0f3fbea9",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su009_su009_pre_PRJNA509910-su009_pre-CELL": {
        "akc_id": "4b96c15b-31d5-4408-8c47-784ad19a5c29",
        "specimen": "c96e4ef1-eada-4efa-b9a1-f18c0f3fbea9",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su009_su009_pre_PRJNA509910-su009_pre-TRB-CLONE": {
        "akc_id": "c44fb362-5873-47b7-8085-3f33dbd50b66",
        "specimen": "c96e4ef1-eada-4efa-b9a1-f18c0f3fbea9",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_post_BCC_PRJNA509910-su010_post_BCC-TRA": {
        "akc_id": "d01d14dd-9bf9-4b3c-b0a0-54fc508183b3",
        "specimen": "feaf45db-0897-4ec3-be06-c9c5339bf144",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_post_BCC_PRJNA509910-su010_post_BCC-TRB": {
        "akc_id": "e7c86b7b-8641-4ac4-bc01-2d3d915d7da8",
        "specimen": "feaf45db-0897-4ec3-be06-c9c5339bf144",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_post_BCC_PRJNA509910-su010_post_BCC-CELL": {
        "akc_id": "bfdd1cfd-4edb-4174-b81d-d084657eb615",
        "specimen": "feaf45db-0897-4ec3-be06-c9c5339bf144",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_post_BCC_PRJNA509910-su010_post_BCC-TRB-CLONE": {
        "akc_id": "2bf8bbfb-ece2-485e-bd51-96faac4a8ca0",
        "specimen": "feaf45db-0897-4ec3-be06-c9c5339bf144",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_post_SCC_PRJNA509910-su010_post_SCC-TRA": {
        "akc_id": "6f7e1ea1-93e9-44e7-baa3-d79870994a04",
        "specimen": "8fca3d1e-3e21-436b-a687-d87a4d5a1145",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_post_SCC_PRJNA509910-su010_post_SCC-TRB": {
        "akc_id": "c4bcafa3-d2bc-4830-9d2a-18666e8b06f2",
        "specimen": "8fca3d1e-3e21-436b-a687-d87a4d5a1145",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_post_SCC_PRJNA509910-su010_post_SCC-CELL": {
        "akc_id": "6acff83d-c606-492a-8f8c-d20f95e4e1da",
        "specimen": "8fca3d1e-3e21-436b-a687-d87a4d5a1145",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_post_SCC_PRJNA509910-su010_post_SCC-TRB-CLONE": {
        "akc_id": "f1ff5a60-66de-46d4-bb5c-bab27b271f8f",
        "specimen": "8fca3d1e-3e21-436b-a687-d87a4d5a1145",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_post_SCC_CD39_PRJNA509910-su010_post_SCC_CD39-TRA": {
        "akc_id": "7a07c80f-3b03-47cb-999d-cb7b2839a399",
        "specimen": "9a5c7eb0-45da-4eac-a7dd-ff119a11f7c5",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_post_SCC_CD39_PRJNA509910-su010_post_SCC_CD39-TRB": {
        "akc_id": "7682410e-0816-49a7-a41b-b0ce286c83ef",
        "specimen": "9a5c7eb0-45da-4eac-a7dd-ff119a11f7c5",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_post_SCC_CD39_PRJNA509910-su010_post_SCC_CD39-CELL": {
        "akc_id": "14d34830-3a4b-4231-9e55-55ec783901cd",
        "specimen": "9a5c7eb0-45da-4eac-a7dd-ff119a11f7c5",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_post_SCC_CD39_PRJNA509910-su010_post_SCC_CD39-TRB-CLONE": {
        "akc_id": "af684493-a24f-446d-a524-d82ad93ab40b",
        "specimen": "9a5c7eb0-45da-4eac-a7dd-ff119a11f7c5",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_pre_BCC_PRJNA509910-su010_pre_BCC-TRA": {
        "akc_id": "3c5d1593-3ebc-4b76-a464-e663be89c4a4",
        "specimen": "f3bd4408-e8a8-4d19-9ea9-22b823e69f8f",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_pre_BCC_PRJNA509910-su010_pre_BCC-TRB": {
        "akc_id": "fbf8c4fd-4439-4b9c-ba09-c3d2f1354457",
        "specimen": "f3bd4408-e8a8-4d19-9ea9-22b823e69f8f",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_pre_BCC_PRJNA509910-su010_pre_BCC-CELL": {
        "akc_id": "e9a27f3a-ee69-4f7a-bc2e-fe89b8a06eec",
        "specimen": "f3bd4408-e8a8-4d19-9ea9-22b823e69f8f",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_pre_BCC_PRJNA509910-su010_pre_BCC-TRB-CLONE": {
        "akc_id": "e3f2ae98-2d89-4f6d-841a-868c22ab6e2a",
        "specimen": "f3bd4408-e8a8-4d19-9ea9-22b823e69f8f",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_pre_SCC_rep1_PRJNA509910-su010_pre_SCC_rep1-TRA": {
        "akc_id": "9c7dcd12-05da-4edd-b6c0-0a4306a066ae",
        "specimen": "c237d39b-5b5f-41e7-bcdc-234c1c3660b0",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_pre_SCC_rep1_PRJNA509910-su010_pre_SCC_rep1-TRB": {
        "akc_id": "d27d434e-04dd-4ee4-b9d5-be3c393e77e1",
        "specimen": "c237d39b-5b5f-41e7-bcdc-234c1c3660b0",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_pre_SCC_rep1_PRJNA509910-su010_pre_SCC_rep1-CELL": {
        "akc_id": "39013701-49a1-43d2-ab55-2ab7c9258d70",
        "specimen": "c237d39b-5b5f-41e7-bcdc-234c1c3660b0",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_pre_SCC_rep1_PRJNA509910-su010_pre_SCC_rep1-TRB-CLONE": {
        "akc_id": "4b996025-c87f-4bde-a77b-55901be1e5c1",
        "specimen": "c237d39b-5b5f-41e7-bcdc-234c1c3660b0",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_pre_SCC_rep2_PRJNA509910-su010_pre_SCC_rep2-TRA": {
        "akc_id": "76060d9c-d571-481e-ab5a-2736b868d703",
        "specimen": "32da32b8-8270-4ae4-acf5-0ec5735f3f8d",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_pre_SCC_rep2_PRJNA509910-su010_pre_SCC_rep2-TRB": {
        "akc_id": "fe944cd3-b005-4d98-b7c3-3c68584fdbcb",
        "specimen": "32da32b8-8270-4ae4-acf5-0ec5735f3f8d",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_pre_SCC_rep2_PRJNA509910-su010_pre_SCC_rep2-CELL": {
        "akc_id": "576a15f5-03b9-43b3-8b68-29da4d420392",
        "specimen": "32da32b8-8270-4ae4-acf5-0ec5735f3f8d",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su010_su010_pre_SCC_rep2_PRJNA509910-su010_pre_SCC_rep2-TRB-CLONE": {
        "akc_id": "8313b5e2-5fc4-4226-b4e0-30f374ddfc99",
        "specimen": "32da32b8-8270-4ae4-acf5-0ec5735f3f8d",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su011_su011_post_PRJNA509910-su011_post-TRA": {
        "akc_id": "6c594565-57a1-475a-939c-a5e74234552a",
        "specimen": "5f8bc767-d12d-433c-85ba-780e8838f958",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su011_su011_post_PRJNA509910-su011_post-TRB": {
        "akc_id": "3d3bfd7f-d955-43db-83de-701cd0c967d2",
        "specimen": "5f8bc767-d12d-433c-85ba-780e8838f958",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su011_su011_post_PRJNA509910-su011_post-CELL": {
        "akc_id": "18cf9c8e-b7a6-4a4a-a9da-d55b2aa0823b",
        "specimen": "5f8bc767-d12d-433c-85ba-780e8838f958",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su011_su011_post_PRJNA509910-su011_post-TRB-CLONE": {
        "akc_id": "c6076b49-f3dc-4aa6-b1b4-6487c3b69604",
        "specimen": "5f8bc767-d12d-433c-85ba-780e8838f958",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su011_su011_pre_rep1_PRJNA509910-su011_pre_rep1-TRA": {
        "akc_id": "a07da864-7a7c-4f32-bc83-95b8483f827b",
        "specimen": "34187e77-b08b-4162-8e28-4bda70b1aaeb",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su011_su011_pre_rep1_PRJNA509910-su011_pre_rep1-TRB": {
        "akc_id": "1bf2128e-bcd9-4a29-82b4-a1b27305edfa",
        "specimen": "34187e77-b08b-4162-8e28-4bda70b1aaeb",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su011_su011_pre_rep1_PRJNA509910-su011_pre_rep1-CELL": {
        "akc_id": "86b4c3fd-bdba-492a-b5fb-c7aae266261d",
        "specimen": "34187e77-b08b-4162-8e28-4bda70b1aaeb",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su011_su011_pre_rep1_PRJNA509910-su011_pre_rep1-TRB-CLONE": {
        "akc_id": "d62bdecf-714c-47ed-b649-af292bc8080c",
        "specimen": "34187e77-b08b-4162-8e28-4bda70b1aaeb",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su011_su011_pre_rep2_PRJNA509910-su011_pre_rep2-TRA": {
        "akc_id": "3ddc24eb-8108-4550-bad5-a5874c7fa48e",
        "specimen": "c5e742de-5ec5-4c01-912e-f75e5e0efdf1",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su011_su011_pre_rep2_PRJNA509910-su011_pre_rep2-TRB": {
        "akc_id": "eb0085bc-f4e2-4c44-b3e6-ac63a4e37f24",
        "specimen": "c5e742de-5ec5-4c01-912e-f75e5e0efdf1",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su011_su011_pre_rep2_PRJNA509910-su011_pre_rep2-CELL": {
        "akc_id": "06fd3f7c-5a40-4f4c-876f-bc64b2f5d291",
        "specimen": "c5e742de-5ec5-4c01-912e-f75e5e0efdf1",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su011_su011_pre_rep2_PRJNA509910-su011_pre_rep2-TRB-CLONE": {
        "akc_id": "67134679-3773-4433-a3b4-4f780ee15051",
        "specimen": "c5e742de-5ec5-4c01-912e-f75e5e0efdf1",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su012_su012_post_PRJNA509910-su012_post-TRA": {
        "akc_id": "66163126-c19f-441d-adee-7b26e9a13376",
        "specimen": "a138fb4b-b5c7-4f32-bbb4-a085eafe0576",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su012_su012_post_PRJNA509910-su012_post-TRB": {
        "akc_id": "1e1bb369-f773-4065-a60e-11d33b0415c9",
        "specimen": "a138fb4b-b5c7-4f32-bbb4-a085eafe0576",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su012_su012_post_PRJNA509910-su012_post-CELL": {
        "akc_id": "70169a86-7977-4468-98e8-c1c0914cdac9",
        "specimen": "a138fb4b-b5c7-4f32-bbb4-a085eafe0576",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su012_su012_post_PRJNA509910-su012_post-TRB-CLONE": {
        "akc_id": "5ff6e9e5-8e32-4bbe-87f9-459ae817b519",
        "specimen": "a138fb4b-b5c7-4f32-bbb4-a085eafe0576",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su012_su012_pre_PRJNA509910-su012_pre-TRA": {
        "akc_id": "56176711-a2ac-4e3a-bf3b-0137a662c0d8",
        "specimen": "0b47e42e-5035-427f-8d24-4d4a39da1af9",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su012_su012_pre_PRJNA509910-su012_pre-TRB": {
        "akc_id": "df88c448-7d29-4132-a073-ba7a51ae8d32",
        "specimen": "0b47e42e-5035-427f-8d24-4d4a39da1af9",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su012_su012_pre_PRJNA509910-su012_pre-CELL": {
        "akc_id": "467d75f3-1744-4acc-b873-ad7752dc7058",
        "specimen": "0b47e42e-5035-427f-8d24-4d4a39da1af9",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su012_su012_pre_PRJNA509910-su012_pre-TRB-CLONE": {
        "akc_id": "5f7ececd-380b-4fb9-9da9-cfb88424c367",
        "specimen": "0b47e42e-5035-427f-8d24-4d4a39da1af9",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su013_su013_post_PRJNA509910-su013_post-TRA": {
        "akc_id": "9d82c75f-20ed-4a5c-93f9-5e0296fe9d0e",
        "specimen": "e3ed0e16-0481-421f-bfd0-4bfabe9df6d9",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su013_su013_post_PRJNA509910-su013_post-TRB": {
        "akc_id": "935b8392-cc56-4d8b-a962-42cf6afd73e9",
        "specimen": "e3ed0e16-0481-421f-bfd0-4bfabe9df6d9",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su013_su013_post_PRJNA509910-su013_post-CELL": {
        "akc_id": "4363c550-9b29-40e2-b1a5-0ae6e071614c",
        "specimen": "e3ed0e16-0481-421f-bfd0-4bfabe9df6d9",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su013_su013_post_PRJNA509910-su013_post-TRB-CLONE": {
        "akc_id": "733fca84-f710-41b7-b1c1-c36df68f9f6d",
        "specimen": "e3ed0e16-0481-421f-bfd0-4bfabe9df6d9",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su013_su013_pre_PRJNA509910-su013_pre-TRA": {
        "akc_id": "340b31bf-3541-454c-bfd3-9a6d2bc208d0",
        "specimen": "2e8792e2-2504-4656-83a5-97959b805206",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su013_su013_pre_PRJNA509910-su013_pre-TRB": {
        "akc_id": "9dc3af4e-0bdf-4931-89fc-566129b9b4d7",
        "specimen": "2e8792e2-2504-4656-83a5-97959b805206",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su013_su013_pre_PRJNA509910-su013_pre-CELL": {
        "akc_id": "a35fe798-17c9-4d3b-98fc-6e51bc66a7c7",
        "specimen": "2e8792e2-2504-4656-83a5-97959b805206",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su013_su013_pre_PRJNA509910-su013_pre-TRB-CLONE": {
        "akc_id": "5e5207f9-87da-4ee3-9e9b-82d16114f288",
        "specimen": "2e8792e2-2504-4656-83a5-97959b805206",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su014_su014_post_PRJNA509910-su014_post-TRA": {
        "akc_id": "6dc25a47-5c9f-4103-9651-17d52475e6a3",
        "specimen": "934e884a-1c43-4e30-b12c-33682ab639b9",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su014_su014_post_PRJNA509910-su014_post-TRB": {
        "akc_id": "054f733d-223c-415c-8779-2811c77dc579",
        "specimen": "934e884a-1c43-4e30-b12c-33682ab639b9",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su014_su014_post_PRJNA509910-su014_post-CELL": {
        "akc_id": "10c7c3a9-2b92-4c3a-8b63-99688696b278",
        "specimen": "934e884a-1c43-4e30-b12c-33682ab639b9",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su014_su014_post_PRJNA509910-su014_post-TRB-CLONE": {
        "akc_id": "1afb7dad-f52e-4d34-a44e-61480cd45ddf",
        "specimen": "934e884a-1c43-4e30-b12c-33682ab639b9",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su014_su014_pre_PRJNA509910-su014_pre-TRA": {
        "akc_id": "fe3351c6-1cf0-4633-9777-a5ab4007926e",
        "specimen": "41bb4eeb-dea3-406f-bb06-8f41283c5e3e",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su014_su014_pre_PRJNA509910-su014_pre-TRB": {
        "akc_id": "d2d19b14-f254-4531-805c-aac10739f098",
        "specimen": "41bb4eeb-dea3-406f-bb06-8f41283c5e3e",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su014_su014_pre_PRJNA509910-su014_pre-CELL": {
        "akc_id": "973d093d-89c1-4699-8e09-70af4f780885",
        "specimen": "41bb4eeb-dea3-406f-bb06-8f41283c5e3e",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan"
      },
      "ReceptorRepertoireSequencingAssay_su014_su014_pre_PRJNA509910-su014_pre-TRB-CLONE": {
        "akc_id": "954e156f-a070-4d78-8a37-65efd91075f3",
        "specimen": "41bb4eeb-dea3-406f-bb06-8f41283c5e3e",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan"
      }
    }
  },
  "@type": "dict"
}
